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In BALB/c mice, susceptibility to infection with the intracellular parasite Leishmania major is 
driven largely by the development of T helper 2 (Th2) responses and the production of 
interleukin (IL)-4 and IL-13, which share a common receptor subunit, the IL-4 receptor alpha 
chain (IL-4R ). While IL-4 is the main inducer of Th2 responses, paradoxically it has been 
shown that exogenously administered IL-4 can promote dendritic cell IL-12 production and 
enhance Th1 development if given early during infection. To investigate the relevance of this 
theory during in vivo infection, a novel BALB/c mouse model lacking IL-4R  expression 




 BALB/c mice) 
was generated by gene targeting and site-specific recombination using the cre/loxP system 
under control of the CD11c locus. Functional characterization showed selective impairment of 









mice became hypersusceptible to disease, presenting earlier and 
increased footpad swelling, necrosis and parasite burdens, upregulated Th2 cytokine responses 
and increased type 2 antibody production as well as impaired classical activation of 




mice was accompanied by a striking 
increase in parasite burdens in peripheral organs such as the spleen, liver and even brain. 
Inflammatory CD11b
+





mice and showed deficiencies in iNOS production resulting in increased 
parasite loads. IL-4R -deficient DCs produced reduced IL-12 but increased IL-10 due to 
impaired DC instruction, with increased mRNA expression of IL-23p19 and activin A, 
cytokines previously implicated in susceptibility to cutaneous Leishmaniasis. Together, these 
data demonstrate that abrogation of IL-4R  signaling on DCs is severely detrimental to the 
host, leading to rapid disease progression and increased survival of parasites in infected 
CD11b
+


























































1.1  Innate and adaptive immunity  
The mammalian immune system is a highly versatile defence system that has evolved to 
recognise, differentiate and eliminate pathogens or other foreign antigens from the body’s 
‘self’ components (Kuby et al., 2006). Functionally, two main branches of the immune 
system exist, termed innate and adaptive immunity. The innate immune response provides 
the first line of defence, occurring rapidly on recognition of antigens. However, innate 
immunity is not specific and does not improve on repeated encounters with the same 
pathogen (Kenneth et al., 2008).  
Innate immunity relies on pattern recognition receptors (PRRs) to recognise common 
pathogen-associated molecular patterns (PAMPs) (Dempsey et al., 2003). Of note, Toll-
like receptors (TLRs), well known signaling PRRs that recognise PAMPs, are essential for 
antibacterial immune responses (Poltorak et al., 1998; Hoshino et al., 1999a), immunity 
against protozoan parasites (Kropf et al., 2004; Abou Fakher et al., 2009) and innate 
antiviral responses (Doyle et al., 2002). PRRs can be found intracellularly and 
extracellularly of phagocytic cells and work in conjunction with other immune cells  to 
provide immunity (Kenneth et al., 2008). 
Central to the innate response are macrophages and neutrophils that recognise, engulf and 
kill invading pathogens. Eosinophils release destructive enzymes, like eosinophil protease 
(EPO), which target extracellular parasites that are too large to be phagocytosed. Basophils 
and mast cells also release a variety of destructive enzymes, cytokines and inflammatory 
molecules. Eosinophils, mast cells and basophils are also important during allergic 
inflammatory reactions. Natural Killer (NK) cells are large granular lymphocytes that kill  
tumour cells or cells infected by intracellular pathogens. The dendritic cells (DCs) 
internalise and degrade foreign pathogens. However, their main role is the presentation of 
pathogen antigens on their cell surface to naïve T lymphocytes to initiate adaptive immune 
responses (Kropf et al., 2004; Kuby et al., 2006; Kenneth et al., 2008).  
In contrast to innate immunity, adaptive immune responses are slower, being acquired over 
time, mount defences that are highly specific and retain a “memory” of the invading 
pathogen which confers life-long immunity to a repeated pathogen. Adaptive immunity 











diverse repertoire of antigen receptors on their cell surface, encoded by gene 
rearrangement. This enables the immune system to recognise and respond to virtually any 
antigen an individual may be exposed to, and build a strong antigen-specific response 
against it. The antigen-receptors of B cells, the B-cell receptors (BCRs) are 
immunoglobulin (Ig) molecules. Upon activation, B cells may differentiate into effector 
plasma cells secreting large quantities of the BCR in the form of antibodies or memory B 
cells providing long-lasting immunity. Cytotoxic T cells (Tc), characterised by expression 
of the CD8 co-receptor, and helper T cells (Th), characterised by expression of the CD4 
co-receptor, are the two main types of T cells. CD8
+
 cytotoxic T cells kill cells infected 
with viruses or other intracellular pathogens whilst CD4
+
 T helper cells release cytokines 
that stimulate other immune cells, which act more directly in the protection against 
infectious pathogens. The antigen-receptors of T cells, the T cell receptors (TCRs) are 
membrane-bound proteins whose function is to signal naïve T cells for activation 
(Dempsey et al., 2003; Kenneth et al., 2008). In addition to TCR signaling, T cell 
activation requires co-stimulatory signaling to promote antigen-specific T cell expansion 
and differentiation and to upregulate cytokine expression. CD28 is the major T cell 
costimulatory receptor and interacts with the B7 ligand family (CD80/CD86), receptors 
that are expressed on antigen-presenting cells (APCs) (Chen and Flies, 2013). Critical to an 
effective immune response is the influence of soluble cytokines in the microenvironment 
of the cells as well as the recognition and presentation of foreign antigens by the APCs. 
1.1.1  Cytokines 
Cytokines are low molecular weight (~ 25 kDa) regulatory proteins secreted by a range of 
immune cells to a variety of stimuli (Brombacher, 2000). The production of cytokines is 
transient and has a short half-life, being constitutively expressed when needed or 
remaining at baseline levels in steady-state. Their mode of action is either autocrine, 
affecting the cells that produce them, paracrine, affecting surrounding cells, or endocrine, 
affecting distant cells (Kenneth et al., 2008). Cytokines play an important role in 
stimulating or inhibiting the differentiation, proliferation or function of immune cells as 
well as modulating the type of immune responses that should be elicited towards a 
particular pathogen (Dempsey et al., 2003). For instance, interferon-  (IFN- ) secreted by 
the T helper 1 (Th1) subset of CD4
+
 T cells and cytotoxic CD8
+
 T cells induce the cellular 
immune response during infection with intracellular pathogens. In contrast, cytokines 
interleukin (IL)-4, IL-5, IL-9, IL-10 and IL-13 produced by the Th2 subset of CD4
+











induce the humoral immune response in response to extracellular pathogens and allergens. 
In addition, cytokines can also direct the differentiation of IL-17-producing Th17 cells 
(Harrington et al., 2005; Weaver et al., 2007) or IL-10 producing regulatory T cells.    
1.1.2  Dendritic cells 
Antigen-presenting cells include dendritic cells, macrophages and B cells. Whilst B cells 
are the most abundant APC population (Moulin et al., 2000), DCs are sparsely distributed 
but are the most efficient in uptake, processing and presentation of antigens to T cells. 
These cells therefore form a crucial link between innate and adaptive immunity. DCs are 
also defined as migratory cells characterised by numerous branched projections, the 
dendrites, which gives the cell its name and aids in uptake, processing and presentation of 
antigens to T cells. DC progenitors in the bone-marrow differentiate into precursor cells 
that home to tissues, where they reside as immature cells with high phagocytic ability, 
sampling their surrounding environment for foreign antigens (Figure 1.1). Following 
infection or tissue damage, the intrinsic properties of immature DCs (Table 1.1) allows 
them internalise antigen, either by receptor-mediated phagocytosis/endocytosis or 
macropinocytosis, mature and migrate to lymphoid organs where they participate in 
antigen-presentation to T cells (Banchereau et al., 2000). Several factors, such as pathogen 
products, bacterial DNA/RNA, viral dsRNA and cytokines, can trigger DC transition from 
immature antigen-capturing cells to mature antigen-presenting cells (Banchereau et al., 
2000). DCs utilise different receptors to recognise antigens for internalization, such as Fc 
receptors for antigen-antibody complexes, C-type lectin receptors for glycoproteins and 
PRRs such as TLRs for pathogen specific molecules (Brandonisio et al., 2004). This 
allows DCs to recognise and respond to a wide range of pathogenic stimuli.  
Mature DCs undergo several phenotypic changes subsequent to antigen-presentation as 
listed in Table 1.1. Morphological changes are also observed, such as increased migratory 
capacity, loss of adhesion molecules and reorganization of the cytoskeleton (Banchereau et 
al., 2000). DCs will express Major Histocompatibility Complex (MHC) molecules at their 
cell surface which bear fragments of pathogen antigens for presentation to naïve T cells. 
DCs carrying MHC Class II molecules present antigen to naïve CD4
+
 Th cells whilst MHC 
Class I molecules present antigen to CD8
+
 cytotoxic T cells. Recognition of MHC-antigen 
complexes by naïve T cells is followed by interaction between co-stimulatory molecules 
expressed by DCs (CD40) and their ligands expressed by T cells (CD40L) (Banchereau et 




























Figure 1.1: The life cycle of dendritic cells at different stages of development. 
DC precursors enter tissue as immature DCs. Upon encounter with pathogens, the intrinsic 
properties of immature DCs, allows them to capture antigen and release cytokines which activate 
eosinophils (Eos), macrophages (Mph) and natural killer (NK) cells to the site of infection. After 
antigen capture, immature DCs migrate to lymphoid organs and acquire a mature phenotype. DCs 
process the captured antigens and present peptide-MHC on their cell surface to antigen-specific T 
lymphocytes. Antigen-presentation by DCs is characterised by different DC properties, which helps 
to induce T cell expansion and differentiation. Activated helper T and cytotoxic T cells migrate to 
the site of infection. The helper T cells secrete cytokines which further activates eosinophils, 
macrophages and NK cells whilst cytotoxic T cells destroy the infected cells. B cell activation 
occurs after contact with T cells and DCs. B cells mature into antibody-secreting plasma cells to 
neutralise the infecting pathogen or opsonise them for improved uptake by phagocytes. Illustration 













Table 1.1:  Properties of immature and mature dendritic cells during development 
Immature DC-Antigen capture Mature DC-Antigen Presentation 
    High intracellular MHC II High surface MHC II 
    High endocytosis Low endocytosis 
    High phagocytosis Low phagocytosis 
High CCR1, CCR5, CCR6 Low CCR1, CCR5, CCR6 
Low CCR7  High CCR7, CD58 
Low CD80, CD86 High CD54, CD86 
Low CD54, CD58 High CD40, CD83, CD80 
Low CD40, CD83, CD68 Low CD68 
Actin cables present Actin cables absent 
 
Once DCs present antigen, a variety of immune effector cells are activated and regulated. 
These include induction of antigen-specific CD4
+
 Th cells and CD8
+
 cytotoxic T cells, B 
cells to secrete antigen-specific antibodies as well as stimulation of mononuclear 
phagocytes, eosinophils and NK cells (Figure 1.1). Expression of chemokines/chemokine 
receptors and cytokines by DCs is also upregulated, the former to guide effector cells and 
recruit circulating DC precursors to the site of injury and draining lymph node and the 
latter, to guide further differentiation of effector T cells most appropriate to combat the 
invading pathogen (Table 1.1) (Banchereau et al., 2000). Given their role in immune 
responses, DCs are flexible cells and provide the necessary information that determines the 
type of immune response that should be elicited. For example, Th1 or Th2 phenotypes are 
dependent on DC production of various cytokines. DCs secrete IL-12 and IL-18, which 
regulate Th1 responses and IFN-  production which in turn, increases the microbicidal 
action of activated macrophages. DC production of anti-inflammatory cytokines, like IL-
10, suppresses the induction of uncontrolled immune responses (Colino and Snapper, 
2003) whilst production of pro-inflammatory cytokines such as, tumor necrosis factor 
(TNF- ), IL-1 and IL-6, on antigen capture are known to induce DC maturation and 














1.1.2.1  Heterogeneity of dendritic cell subsets in humans 
In humans, two pathways of DC development have been identified, myeloid and lymphoid 
DC development. Myeloid DCs were shown to differentiate from human monocytes in the 
presence of granulocyte macrophage colony-stimulating factor (GM-CSF) and IL-4 in vitro 
(Romani et al., 1994; Wu and Liu, 2007). Lymphoid DCs were recognised based on the 
fact that lymphoid tissue-resident DCs expressed markers, such as CD8 , CD4 and CD25, 
that are associated with lymphoid cells (Wu and Liu, 2007). DC subsets in humans include 
CD11c
+ 
myeloid conventional DCs (cDCs) found circulating in the blood, CD11c
+
 
lymphoid cDCs resident in lymphoid tissue, CD11c
-
 plasmacytoid DCs (pDCs) found in 
lymphoid organs and epidermal Langerhans cells (LC) along with dermal DCs in the skin 
(Brandonisio et al., 2004; Segura et al., 2012). Conventional DCs are directly involved in 
antigen-presentation and activation of naïve T cells whilst pDCs generate large amounts of 
type I interferons, particularly important during viral infections (Gilliet et al., 2008; 
Cervantes-Barragan et al., 2012).  
1.1.2.2  Heterogeneity of dendritic cell subsets in mice 
Studies in mice have provided more detailed insight into the development and 
differentiation of DC populations. Both myeloid and lymphoid DC development has been 
identified and can be further sub-divided into skin DCs, plasmacytoid DCs, follicular DCs 
and monocyte-derived DCs (Figure 1.2). Differentiation of all DC subsets, with the 
exception of follicular DCs, arises from hematopoietic stem cells (HSC) in the bone-
marrow that give rise to common lymphoid progenitors (CLP) and common myeloid 
progenitors (CMP) as illustrated in Figure 1.2. Careful studies on murine precursor cells 
transferred into irradiated mice have shown that all DC subsets can be generated from both 
myeloid and lymphoid precursors (Manz et al., 2001), which give rise to common 
macrophage-DC progenitors (MDP) that further differentiate into common DC-progenitors 
(CDP). CDPs exclusively give rise to myeloid and lymphoid DCs through a precursor DC 
population, the pre-DCs (Figure 1.2) (Shortman and Naik, 2007; Wu and Liu, 2007).  
Myeloid and lymphoid DCs differ in phenotype, function and localization. Myeloid DCs 
are known for their migratory properties and migrate from peripheral tissues to lymphoid 
organs whilst lymphoid DCs lack migratory functions and reside in lymphoid tissue. 
Myeloid DCs include DC subsets found in the skin, lung, intestinal tract, liver, kidneys, 
LN, spleen and thymus whilst lymphoid DCs are resident only in lymphoid organs (LN, 











bone-marrow cultures stimulated with granulocyte macrophage colony-stimulating factor 
(GM-CSF) (Scheicher et al., 1992). In contrast, Flt3 ligand (tyrosine kinase 3 ligand) has 
been reported to induce the differentiation of both myeloid and lymphoid DCs from mouse 
bone-marrow progenitors (Lyman and Jacobsen, 1998) and upon in vivo injection 














Figure 1.2: Differentiation of dendritic cells from haematopoietic stem cells.  
Haematopoietic stem cells (HSCs) differentiate into common lymphoid progenitors (CLP) and 
common myeloid progenitors (CMP) which can differentiate into macrophage-dendritic cells (DC) 
progenitors and give rise to common DC progenitors (CDP) and monocytes. CDPs specifically give 
rise to DCs through pre-DC precursor cells (pre-DC). CDPs can also give rise to plasmacytoid DCs 
(pDCs). pre-DCs migrate to lymphoid and peripheral tissues where they differentiate into either 
lymphoid or myeloid DCs. Monocytes give rise to monocyte-derived DC subsets in peripheral 
tissues. Myeloid DC differentiation is denoted by the solid line (   ) and lymphoid DC 
differentiation is denoted by the broken line (     ). Illustration drawn from previous publications 
(Shortman and Liu, 2002; Shortman and Naik, 2007; Wu and Liu, 2007; Kushwah and Hu, 2011). 
 
Myeloid and lymphoid DC subsets are differentiated by the CD8  marker, which is 
expressed as a homodimer by lymphoid DCs, but absent from myeloid DCs (Pulendran et 
al., 1997; Vremec and Shortman, 1997). Along with the CD8 + lymphoid DCs, there are 
the CD8
-















lymphoid DCs in turn are further divided by the expression of CD4
+








 DCs (Shortman and Naik, 2007). Myeloid and lymphoid DCs do 
share some common traits such as the expression of high levels of the integrin  chain 
CD11c, MHC molecules and co-stimulatory or adhesions molecules. In addition, both 
subsets have been shown to efficiently prime antigen-specific CD4
+
 T cells (Maldonado-
Lopez et al., 1999). 
Lymphoid DCs reside in the T cell-rich areas of the spleen and lymph nodes whereas 
myeloid DCs localise to the marginal zone bridging channels of the spleen, but can be 
induced to home to the T cell-rich areas upon stimulation by pathogen products or pro-
inflammatory signals (Banchereau et al., 2000). The myeloid CD8 - DCs are more 
phagocytic than CD8
+
 lymphoid DCs, whilst the latter produces higher levels of IL-12. 
IL-12 induces potent production of IFN-  in CD8
+




 T cells 
and plays a role in cytotoxicity of NK cells (Pulendran et al., 1997). Thus, CD8 + DCs 
tend to induce a biased Th1 response whereas CD8
- 
DCs tend to induce a biased Th2 
response owing to their production of Th1 inhibitory cytokines, IL-10 and transforming 
growth factor (TGF- ). A unique property of CD8
+
 lymphoid DCs is their ability to 
engulf and cross-present exogenous antigens through MHC Class I (Shortman and Liu, 
2002; Kushwah and Hu, 2011). 
Myeloid skin DCs include Langerhans cells and dermal DCs, which represent the model 
migratory DCs. LCs express higher levels of the Birbeck-granule-associated molecule, 





dermal DCs with different roles in initiating immune responses in the skin (Brewig et al., 
2009; Henri et al., 2010; King et al., 2010). These DCs have a slow turnover and initiate 
immune responses to pathogens that gain access to epidermal or dermal skin layers. 
Development of LC DCs appears to be dependent on TGF-  since TGF- -deficient mice 
are devoid of LC DCs (Borkowski et al., 1996). LC DCs migrate from the skin carrying 
antigenic information to the draining LN. However, controversy remains as to whether LC 
DCs themselves present the antigen to T cells or whether they pass the antigen on to 
CD8
+
 lymphoid DCs for final presentation (Moll et al., 1993; Ritter et al., 2004; Allan et 
al., 2006). On the other hand, dermal DCs have been shown to not only carry parasite 
antigen from the skin to the draining LN but also to present it to antigen-specific naïve T 











Plasmacytoid DCs can be differentiated from both lymphoid and myeloid precursors and 
are relatively long-lived cells found circulating in both lymphoid and non-lymphoid 
organs. pDCs lack normal dendritic form and instead, morphologically resemble antibody-
producing B-lineage plasma cells. pDCs secrete type I interferons, which are key cytokines 
involved in viral immunity and contributes to the activation of NK, B and T cells as well as 
myeloid DCs (Kushwah and Hu, 2011). pDCs are differentiated based on low/intermediate 
expression of CD11c and MHC II markers and selective expression of Siglec-H and 
PDCA-1 (Randolph et al., 2008). pDCs are generally poor activators of T cell proliferation 
because these cells are incompetent at antigen capture, processing and presentation 
(Colonna et al., 2004). However, upon activation with IL-3 or pathogen products, murine 
pDCs differentiate into conventional DC morphology, acquire a mature phenotype and 
instruct adaptive immunity through production of IL-12 (Shortman and Liu, 2002; 
Randolph et al., 2008).  
Follicular DCs (FDCs) are a non-migratory population located in B cell-rich areas and 
germinal centres of lymphoid organs. FDCs sustain the viability, growth and 
differentiation of activated B cells. Interestingly, FDCs develop from mesenchymal 
precursors unlike other DC subsets that are derived from bone-marrow haematopoietic 
stem cells. FDCs express a unique set of surface markers, including all complement 
receptors, which allows them to capture and display antigen-antibody complexes on their 
cell surface for activation of B cells. B cells that recognise the antigen-antibody complexes 
on FDCs process the antigen and present it as peptide-MHC complexes to antigen-specific 
T cells (Banchereau and Steinman, 1998).  
Monocytes serve as precursor cells in peripheral tissues and can give rise to monocyte-
derived DCs (or macrophages) under inflammatory or steady-state conditions in addition to 
epidermal LC DCs after skin inflammation (Randolph et al., 1999; Wu and Liu, 2007; 
Kushwah and Hu, 2011). Monocyte-derived DCs take up antigen and migrate to the 
draining LN for presentation to antigen-specific T cells. Among the monocyte-derived 
DCs, the inflammatory DCs, also known as TNF- /inducible nitric oxide synthase (iNOS)-
producing “TipDCs”, produce TNF- , nitric oxide, IL-12 and stimulate Th1 cells. These 
monocyte-derived inflammatory DCs are derived from the Ly6C
+
 monocytes and can be 
distinguished from normal DC subsets by their high level expression of CD11b along with 
CD11c and the distinct absence of CD4 or CD8 expression (Shortman and Naik, 2007). 















 T helper cell differentiation 
CD4
+
 Th cells are important in orchestrating adaptive immunity and immunological 
memory to a variety of stimuli. They initiate, regulate or suppress adaptive immune 
responses in response to infection. Hence, when their numbers are low or functions are 
lost, an individual becomes susceptible to a host of infectious disorders. During TCR 
activation of naïve Th cells via stimulation of their cognate antigen by DCs, CD4
+
 T cells 
may differentiate into four distinct lineages. Each lineage has a distinct set of cytokines, 
signalling transducer and activator of transcription (STAT) proteins and transcription 
factors that promote its differentiation as illustrated in Figure 1.3. The ability of Th cells to 
differentiate into any of these lineages during an immune response depends on the nature 
and quantity of the pathogen, the type of APC and co-stimulatory molecules, their effector 
function and location, their pattern of cytokine secretion and their expression of specific 
master transcription factors (Onah and Nawa, 2000; Zhu et al., 2010).  
IL-12 and IFN- act in collaboration with STAT1 and transcription factor T-bet to drive 
the differentiation of CD4
+
 Th1 cells that secrete IFN-  and IL-2 (Figure 1.3). Th1 cells are 
important for the activation of macrophages and cytotoxic CD8
+
 T cells, production of 
protective IgG antibodies and delayed-type hypersensitivity (DTH) reactions in clearance 
of intracellular pathogens (Zhu et al., 2010). T-bet acts by upregulating expression of the 
IL-12 receptor (IL-12R 2) which in turn stimulates further IL-12 and IFN-  secretion. 
IFN-  produced by the differentiated cell creates a positive feedback loop in promoting 
further cell differentiation (Zhu et al., 2010).  
Th2 cells secrete IL-4, IL-13 and IL-10, which are important for the clearance of 
extracellular parasites (Zhu et al., 2010) and mediate asthma and allergic responses to 
ubiquitous antigens which can lead to anaphylactic shock and death (Holgate, 1999). Th2 
cell differentiation is driven by IL-4 and signaling via the IL-4 receptor alpha chain (IL-
4R ), which together signal the STAT6 pathway and the Th2 master regulator, GATA3 
(Figure 1.3) (Zhu et al., 2010). Both Th1 and Th2 responses counter-regulate each other. 
T-bet and STAT4 promote IFN-  secretion and increased IL-12R 2 expression in Th1 
cells, but expression of Th2 associated GATA3 is suppressed. Similarly, in Th2 cells, 











downregulated. Moreover, IL-10 inhibits Th1 responses whilst IL-12 suppresses Th2 
responses (Zhu et al., 2010).  
Differentiation of CD4
+
 IL-17-producing cells (Th17) cells is induced by IL-23, IL-6 and 
TGF-β1 which together signal ROR T and STAT3 for defence against extracellular 
bacteria, fungi and autoimmune diseases (Figure 1.3) (Weaver et al., 2007; Zhu et al., 






 regulatory T cells (Tregs) relies on 
stimulation with TGF-  and IL-2, whilst IL-6 plays an inhibitory role in the commitment 
of this cell lineage. Tregs produce IL-10 and TGF-  which are cytokines that tend to 
inhibit rather than activate T cell responses. Thus, Tregs and their inhibitory cytokines 
exert a regulatory role which is important in maintaining self-tolerance and immune 
modulation during exaggerated immune responses.  
Although the Th1/Th2/Th17/Treg paradigm is widely accepted, other Th lineages have 
also been proposed, including Th3 cells (TGF- -producing CD4
+
 T cells) (Weiner, 2001), 
Tr1 cells (IL-10-producing CD4
+
 T cells) (Groux et al., 1997), Th9 cells (IL-9-producing 
CD4
+
 T cells) (Veldhoen et al., 2008), Th5 cells (IL-5-producing CD4
+
 T cells) 
(Kurowska-Stolarska et al., 2008) and T follicular helper (Tfh) cells (King et al., 2008; 
Zhu and Paul, 2010). However, controversy still remains as to whether these cells represent 
distinct lineages separate from the four known lineages since the cytokines they produce 
and transcription factors they express are also shared among the four known cell lineages 
and therefore not unique (Zhu et al., 2010). In addition, T cells are more plastic than 
initially thought and can shift between either of the Th lineages. For these reasons, further 
investigations are required to uncover the relationships between Th1/Th2/Th17/Treg and 













































 T helper cell differentiation. 
Dendritic cells present MHC Class II-loaded antigens to naïve CD4+ Th0 cells. Naïve CD4+ Th0 
cells recognise the loaded antigen by their T cell receptor (TCR) and differentiate into an effector T 
cell lineage depending on the cytokine milieu in the local environment. Th1 differentiation is 
influenced by IL-12, IL-18 and IL-2 along with T-bet/STAT4 whilst Th2 differentiation is 
influenced by IL-4 together with GATA-3/STAT6. Inflammatory cytokines IL-23, IL-6, TGF-  
and ROR T/STAT3 drive the differentiation of Th17 cells. TGF-  along with FoxP3 induces the 
differentiation of immunosuppressive regulatory T cells (Treg). Illustration adapted and redrawn 
from previous publications (Brombacher, 2000; Kenneth et al., 2008; Zhu et al., 2010; Craft, 
2012). 
 
1.2  Interleukin-4 and Interleukin-13 
1.2.1  Interleukin-4 
Interleukin-4 (IL-4) plays a critical role in initiating and regulating Th2-type immune 
responses (Himmelrich et al., 2000). Murine IL-4 is 14-19 kDa glycoprotein co-localized 
on chromosome 11 together with IL-5 and IL-13 genes. It is produced by CD4
+
 Th2 cells 
(Launois et al., 1995) (Figure 1.3) in addition to NK T cells (Yoshimoto and Paul, 1994), 











and eosinophils (Sabin et al., 1996). Apart from regulating the differentiation of Th2 cells, 
IL-4 also controls immunoglobulin class switching by activated B cells. IL-4 specifies 
human B cells to switch to the expression of IgE and IgG4 (Gascan et al., 1991) whilst in 
mice, to IgE and IgG1, with the concomitant suppression of IgM, IgG2a and IgG2b 
(Coffman et al., 1986; Snapper et al., 1988). IL-4 suppresses the expression of IFN-  
(Nelms et al., 1999) and increases the expression of MHC II molecules (Noelle et al., 
1984), Fc epsilon receptors (CD23) (Defrance et al., 1987), co-stimulatory molecules 
CD80 and CD86 (Stack et al., 1994), IL-4 receptor (Ohara and Paul, 1987) and together 
with TNF- , enhances endothelial cell adhesiveness of T cells (Thornhill et al., 1991). 
Although IL-4 has been shown to be the primary inducer of Th2 responses, studies have 
reported IL-4-independent Th2 differentiation (Noben-Trauth et al., 1997; Brombacher, 
2000; Mohrs et al., 2000; Ritz et al., 2002; Cunningham et al., 2004). Furthermore, Th2 
differentiation and production of Th2 cytokines was also found to be independent of IL-4, 
IL-4R signaling and STAT6 regulation during infection (Noben-Trauth et al., 1997; 
Finkelman et al., 2000; Jankovic et al., 2000). 
1.2.2  Interleukin 13 
Murine interleukin-13 (IL-13) is an immunoregulatory cytokine with a molecular weight of 
10-14 kDa (Hershey, 2003) and co-localizes on chromosome 11 together with the genes for 
IL-4, IL-5 and IL-3. Like IL-4, murine IL-13 also promotes upregulation of MHC II 
antigens, co-stimulatory (CD80/CD86) molecules and adhesion molecules. However, 
unlike IL-4, murine IL-13 has been shown not to affect Th2 differentiation, B cell 
switching or upregulation of the low-affinity IgE receptor (CD23), probably due to the 
absence of a functional IL-13 receptor on those cells in mice. On the other hand, human B 
lymphocytes do respond to IL-13 (Brombacher, 2000). Activated Th2 cells, NK T cells, 
mast cells, basophils, dendritic cells and NK cells produce IL-13 (McKenzie et al., 1993; 
de Saint-Vis et al., 1998; Hoshino et al., 1999b; Brombacher, 2000). IL-13 also has 
immunosuppressive and anti-inflammatory effects on macrophages and monocytes, 
including suppression of pro-inflammatory cytokines and chemokines. Nitric oxide (NO) 
production along with antibody-mediated cytoxicity is also inhibited by IL-13. IL-13 also 
exerts an effect on innate immune cells and is responsible for activating mast cells and 
modulating eosinophil function (Hershey, 2003). IL-13 production is also crucial for the 
expulsion of intestinal parasites during Nippostrongylus brasiliensis infection (McKenzie 











Schistosoma mansoni (Chiaramonte et al., 1999) and is a mediator of allergic asthma 
(Grunig et al., 1998) and anaphylaxis (Fallon et al., 2001).  
1.2.3  The IL-4 and IL-13 receptor complexes 
The common functions between IL-4 and IL-13 can be attributed to the shared IL-4 
receptor alpha (IL-4R ) chain (Brombacher, 2000). This was demonstrated in competitive 
studies wherein mice treated with IL-4 antagonists or anti-IL-4R  antibodies inhibited 
both IL-4 and IL-13 responses (Aversa et al., 1993; Zurawski et al., 1993; Hilton et al., 
1996). The IL-4R is a 140 kDa chain and serves as a common monomer in both the type I 
and type II IL-4 receptor complexes (Figure 1.4). It is expressed in fairly low numbers on 
haematopoietic, endothelial, epithelial, muscle, fibroblast, hepatocytes and brain tissue 
(Nelms et al., 1999). IL-4R  associates with the gamma common ( c) to form the type I 
IL-4 receptor and with the 65-70 kDa IL-13-binding receptor chain (IL-13R 1) to form the 
type II IL-4/IL-13 receptor (Figure 1.4) (Nelms et al., 1999). IL-4 binds the IL-4R chain 
with high affinity but IL-13 binds the IL-13R 1 chain with low affinity. However, when 
paired with the IL-4R chain, IL-13 binds the IL-13R 1 chain with high affinity forming 
an active signaling unit (LaPorte et al., 2008). Expression of IL-13R 1 is absent on human 
or murine T cells but constitutively expressed on B cells, epithelial cells and monocytes in 
both mice and humans (Gauchat et al., 1997; Graber et al., 1998). IL-13 shows a higher 
binding affinity for the 2 chain of the IL-13 receptor (IL-13R 2) which is a 55-60 kDa 
protein (Figure 1.4). Up until recently, IL-13R 2 was considered a decoy receptor for IL-
13 devoid of signal transduction since its short cytoplasmic domain does not contain any 
binding motifs for signaling molecules (MacDonald, 2006). However, recent reports have 
demonstrated a signaling pathway for IL-13 through the IL-13R 2 chain, which induces 
production of TGF- 1 and mediates fibrosis (Fichtner-Feigl et al., 2006). In human and 
mouse models, soluble forms of both IL-4R  and IL-13R 2 exist (Figure 1.4), capable of 
binding IL-4 and IL-13 with high affinity. In doing so, the soluble receptors can act as 
competitive inhibitors of both IL-4 and IL-13 and modulate their effector responses (Zhang 

































Figure 1.4: The IL-4 and IL-13 receptor complexes. 
IL-4 interacts with the IL-4R  chain in combination with either the c to form the Type I receptor 
or with the IL-13R 1 to form the Type II receptor complex. The IL-4R  chain signals via the 
JAK1/STAT6 pathway whilst JAK3 associates with the c chain and JAK2 with the IL-13R 1. IL-
13 interacts with the type II receptor complex (through IL-13R 1) or with the IL-13R 2. A 
signaling pathway for IL-13 via IL-13R 2 has recently been identified. TNF-  induces 
upregulation of IL-13R 2 expression. IL-13 then binds to the IL-13R 2 which activates AP-1 to 
induce gene expression and secretion of soluble TGF- . Illustration adapted and redrawn from 




1.2.4  Mechanisms of IL-4 and IL-13 signaling through the IL-4R  chain   
Both IL-4 and IL-13 signaling via the IL-4R  chain involves activation of the Janus-family 
kinases (JAK) for signal transduction. JAK1 associates with the IL-4R  chain while JAK3 
associates with the c chain and JAK2 with the IL-13R 1 (Figure 1.4) (Yin et al., 1994; 
Murata et al., 1996; Nelms et al., 1999). IL-4 engagement with the IL-4R  chain results in 
tyrosine phosphorylation of the IL-4R  chain itself as well as phosphorylation of STAT6 
and IRS-2 (Insulin receptor substrate 2) by JAKs, which then associates with the 
phosphoinositol-3 kinase (PI-3) (Figure 1.4) (Nelms et al., 1999; Brombacher, 2000). 
Macrophages in STAT6-deficient mice had impaired IL-13-mediated functions which 











1.4) (Takeda et al., 1996; Brombacher, 2000). IL-13 signaling through the IL-13R 2 first 
requires engagement of the IL-13R 1/IL-4R  complexes in conjunction with TNF-  
signaling which increases surface expression of IL-13R 2. IL-13 then binds to the IL-
13R 2 and, through activation of the transcription factor, AP-1, drives secretion of TGF-
(Figure 1.4) (Fichtner-Feigl et al., 2006; MacDonald, 2006).  
1.2.5  Macrophage activation   
Macrophages exhibit significant plasticity, which allows them to respond to various 
environmental signals and change their activation phenotype (Mosser and Edwards, 2008). 
Tissue macrophages have been classified into three distinct subsets, which together 
regulate inflammation and wound healing (Figure 1.5) (Gordon, 2003). Classically 
activated macrophages occur during Th1 responses and mediate cellular immunity against 
intracellular pathogens via the production of pro-inflammatory cytokines (IL-1 and TNF), 
reactive oxygen species (ROS) and nitric oxide. Activation of classical macrophages is 
mediated by IFN-  and TNF signaling (Mosser and Edwards, 2008; Classen et al., 2009). 
Conversely, alternatively activated macrophages, also known as wound-healing 
macrophages, are activated by Th2 cytokines, IL-4 and IL-13, signaling through the IL-
4R  chain (Classen et al., 2009). Studies have shown that alternative macrophages have 
important roles not only in regulating wound healing (Mosser and Edwards, 2008) but also 
in defense against helminths (Herbert et al., 2004) and fungal infections (Muller et al., 
2007) whilst others have demon trated a detrimental role during infection with protozoan 
parasites (Holscher et al., 2006). Alternatively activated macrophages upregulate the 
expression of specific markers such as, arginase I (Arg I), mannose receptor CD206 
(Mrc1) and resistin-like alpha (RELM ) (Figure 1.5). Importantly, IL-4 inhibits iNOS 
expression thereby inhibiting classically activated macrophages. The third macrophage 
subset, termed ‘regulatory’ macrophages, secrete large amounts of IL-10 in response to Fc 
receptor-γ ligation (Sutterwala et al., 1998; Mosser and Edwards, 2008). 
Recently it has been shown that murine DCs can also respond to IL-4 in vivo and in vitro 
and become alternatively activated in a manner similar to that described for alternatively 
activated macrophages, by upregulating multiple alternative activation markers such as 
Ym-1, Dectin-1, mannose receptor and RELM-  (Cook et al., 2012). Moreover, 
expression of RELM- on these alternative DCs was found to play a role in priming 











reported. These DCs were found to secrete iNOS, similar to classically activated 
macrophages, and contributed to resistance during infection with L. monocytogenes 
(Serbina et al., 2003) and Brucella sp (Copin et al., 2007). These data highlight that 
classical and alternative activation of DCs is also possible although the mechanisms 





















Figure 1.5: Activation of classical, alternative and regulatory macrophages. 
Classical activation of macrophages is induced by Th1 cytokines, such as IFN-γ, in combination 
with microbial stimuli (e.g. LPS) and secrete NO and pro-inflammatory cytokines. Alternative and 
regulatory macrophages are activated by Th2 cytokines (IL-4/IL-13). Alternatively activated 
macrophages secrete IL-4 and Arg I that favor parasite growth have an anti-inflammatory 
responses. Regulatory macrophages produce high amounts of IL-10 that can suppress immune 


















1.3  Leishmaniasis 
1.3.1  Background 
Leishmania spp. are obligate, intracellular protozoan parasites that are transmitted by 
female sand flies of the Phlebotomus spp. and cause the disease, Leishmaniasis (Alexander 
et al., 1999; Herwaldt, 1999). Leishmaniasis is characterised by different clinical 
manifestations which depend on both the genetic background of the host and the 
Leishmania spp. initiating infection. These include cutaneous Leishmaniasis, caused by L. 
major, L. tropica and L. mexicana; mucocutaneous Leishmaniasis, caused by L. 
braziliensis; and visceral Leishmaniasis, caused by L. donovani, L. infantum, L. chagasi or 
L. amazonensis (Figure 1.6) (Alexander et al., 1999). Cutaneous Leishmaniasis is localized 
to dermal tissue surrounding the site of inoculation, but parasites may migrate to draining 
lymph nodes and visceralise during chronic infection. Mucocutaneous Leishmaniasis (also 
known as “Espundia”) results in total or partial deconstruction of the mucous membranes 
of the nose, mouth and genitalia. Visceral Leishmaniasis (also known as “Kala -azar”) is 
usually fatal if left untreated and results from the metastatic spread of parasites to internal 
organs such as the spleen and liver (Alexander et al., 1999). A fourth clinical symptom, 
post Kala-azar dermal Leishmaniasis (PKDL) has been identified as a squeal to “kala-azar” 
following treatment and appears in a dermatotropic form of L. donovani infection, serving 








Figure 1.6: Clinical manifestations of Leishmaniasis in humans. 
Infection with L. major, L. tropica or L. mexicana causes localized cutaneous Leishmaniasis and 
presents as ulcers on the skin. Mucocutaneous Leishmaniasis results from infection with L. 
braziliensis and leads to progressively destructive ulcerations of the mucosa. Visceral 
Leishmaniasis caused by L. donovani or L. infantum is fatal if left untreated and leads to 
enlargement of the spleen and liver due to the systemic spread of parasites. Post-kala-azar dermal 
Leishmaniasis (PKDL) is a complication of visceral Leishmaniasis following treatment and 
presents as lesions on the skin.  
L. major,   L. tropica   
L. mexicana 











Currently there is no effective vaccine for Leishmaniasis and control depends on early 
detection and prompt treatment to prevent death from visceral Leishmaniasis and morbidity 
from cutaneous and mucosal Leishmaniasis (Herwaldt, 1999). 
1.3.2  Epidemiology of Leishmaniasis 
It is estimated that Leishmaniasis is endemic in 88 countries, with 12 million people 
currently infected and a population of 350 million at risk of contracting the disease 
(Sharma and Singh, 2009). The incidence of disease is approximately 1.5 million per 
annum for cutaneous Leishmaniasis and 500 000 per annum for visceral Leishmaniasis 
(Desjeux, 2004). Disability-adjusted life years (DALYs) lost due to Leishmaniasis is close 
to 2.4 million (Desjeux, 2004). Greater than 90% of all cutaneous Leishmaniasis cases 
occur in Afghanistan, Iran, Saudi Arabia, Syria, Brazil and Peru whilst the tropical and 
sub-tropical regions of Africa, Asia, Southern Europe as well as South and Central 
America are highly endemic for visceral Leishmaniasis (Sharma and Singh, 2009). Thus 
far, over 21 Leishmania species are known to infect humans and 30 Phlebotomus sandfly 
species are identified as vectors (Desjeux, 2004). 
There has been a steady, worrying increase in the incidence of Leishmaniasis. Increases 
have been mainly attributed to behavioural and environmental changes, including the 
development of new settlements, building of new dams, deforestation and migration from 
rural to urban areas. The rising incidence of Leishmaniasis is evident in the recent 
outbreaks that have been reported. The incidence of CL in Brazil increased from 21,800 
cases in 1998 to 60,000 cas s in 2003 (Desjeux, 2004). In 2009, the deadliest outbreak of 
visceral Leishmaniasis began in Sudan, with more than 6,363 new cases of infection and 
303 fatalities (WHO, 2010). Moreover, individual risk factors such as poverty, 
malnutrition, mounting anti-leishmanial drug resistance and immunosuppression owing to 
HIV co-infection has contributed to the rising incidence of disease. During HIV co-
infection, the loss of CD4
+
 T cells implies a loss of T cells capable of recognizing 
Leishmania antigens and stimulating a response against it (Olivier et al., 2003). Moreover, 
the Leishmania parasite accelerates the replication of the HIV virus promoting the 
development of AIDs and in doing so, reduces the life expectancy of HIV
+
 patients 
(Cacopardo et al., 1996; Cruz et al., 2006). Thus, although it is clear that Leishmania is an 
established disease, these complicating factors enable its classification as a re-emerging 











1.4  Cutaneous Leishmaniasis 
Like all other Leishmania parasites, cutaneous Leishmania parasites have a digenetic life 
cycle and exist in two distinct morphologies. The flagellated promastigote forms multiply 
and develop extracellularly within the digestive tract of the female sandfly vectors, and are 
transmitted to the mammalian host during a blood meal. Once inside the mammalian host, 
promastigote parasites infect phagocytic macrophages, neutrophils and even dermal DCs 
(Figure 1.7) (Ng et al., 2008; Peters et al., 2008; Ribeiro-Gomes et al., 2012). Within the 
phagolysosomes of macrophages, the promastigote parasites transform into non-motile 




















Figure 1.7: Life cycle of Leishmania major parasites. 
A. Metacyclic promastigote L. major parasites are regurgitated into the skin of a mammalian host 
by the bite of an infected female sandfly. The parasites are phagocytosed by macrophages, where 
they survive in phagolysosomes, and transform into replicating amastigotes. When infected 
macrophages burst, amastigotes infect other macrophages, or infected macrophages are ingested by 
the sandfly once again to repeat the cycle. Amastigote parasites then transform into flagellate 
promastigotes in the gut of the sandfly and wait to be transmitted when the sandfly takes another 
blood meal. B. In a murine model of L. major infection, mice are infected with promastigote 
parasites via subcutaneous, intravenous, intradermal or intranasal routes and follow the same life 
cycle as described for the natural route of infection by sandflies. Illustration drawn from previous 
publications (Bogdan et al., 1996; Sacks and Noben-Trauth, 2002; Lipoldova and Demant, 2006). 
A.     Sandfly L. major infection 











Infected macrophages may then burst releasing amastigote parasites that spread the 
infection by infecting other cells, or they can be ingested by a feeding sandfly to repeat the 
cycle (Figure 1.7) (Alexander et al., 1999; Murray et al., 2005). 
To identify correlates of immune protection, which may aid in vaccine design and 
therapeutic strategies, experimental models of cutaneous Leishmaniasis have been 
established in which disease is induced by infecting mice subcutaneously with L. major. 
The L. major mouse model provides an excellent model system for investigating the 
mechanisms underlying Th1/Th2 cell differentiation relating to resistance/susceptibility to 
intracellular infection. Most laboratory strains (such as C57BL/6) are able to control L. 
major disease progression and heal lesions, raising a polarised Th1 response (Figure 1.8). 
In contrast, due to a genetic predisposition, susceptible BALB/c mice show progressive 
lesion development with dissemination of parasites to visceral organs which is associated 
with a polarized Th2 response following infection (Sacks and Noben-Trauth, 2002) (Figure 
1.8). However, evidence also suggests that a low dose of L. major is capable of inducing a 
protective Th1 response in susceptible BALB/c mice whilst only a transient Th2 response 
is observed in resistant C57BL/6 mice due to the expansion of IFN- -producing CD8
+
 T 













Figure 1.8: Disease progression in a murine model of Leishmania major infection. 
Laboratory strains of mice are infected by needle inoculation of a large number of promastigote 
parasites (104-107) into subcutaneous, intravenous, intradermal or intranasal sites. The susceptible 
BALB/c mice develop an IL-4 driven Th2 response with production of IL-4 and IL-13. There is no 
elimination of parasites leading to progressive disease. In contrast, the resistant C57BL/6 mice 
develop an IL-12 driven Th1 response characterized by the production of IFN- . Parasites are 
eliminated leading to a healing response. Illustration drawn from previous publications (Bogdan et 











1.4.1  Evasion of L. major parasites from primary host immune responses during 
infection 
The Leishmania parasite expresses specific virulence factors which aid in establishing 
intracellular parasitism by: (a) evading humoral responses, (b) attachment and 
phagocytosis of parasites, (c) intracellular survival of endocytosed parasites, (d) 
transformation from promastigote to amastigote form and (e) replication of amastigotes 
(Chang and McGwire, 2002). Among the virulence factors are two important molecules, 
the metalloprotease gp63 and lipophosphoglycan (LPG). Leishmania Gp63 interacts with 
the complement protein C3b and converts it to an inactive state, C3bi. Since C3b is a 
potent immune opsonin critical in activating complement-mediated cell lysis for clearance 
of pathogens, its inactivation to C3bi shifts complement function toward phagocytosis and 
promotes uptake of Leishmania by means of C3b receptors (CR1 a d CR3) on innate 
phagocytic cells such as macrophages, neutrophils and dendritic cells. Gp63 has also been 
associated with suppression of oxidative burst (Sorensen et al., 1994; Bogdan et al., 1996; 
Alexander et al., 1999). Aside from protecting the Leishmania parasite against complement 
and oxidative burst, Gp63 also promotes inactivation of protective host cell signaling 
pathways thereby favouring Leishmania survival and progression within its host (Olivier et 
al., 2012). 
In the case of L. major, LPG facilitates attachment and entry of promastigote and 
amastigote parasites into macrophages (Bogdan et al., 1996) and like Gp63, protects the 
parasites against complement-mediated lysis. In addition, LPG transiently inhibits 
phagosome maturation which gives the promastigotes sufficient time to differentiate into 
the more oxidative-resistant amastigotes (Desjardins and Descoteaux, 1997; Peters and 
Sacks, 2006). LPG also acts as a protective shield, physically blocking oxygen radicals  
from reaching the parasite surface (Alexander et al., 1999). Leishmania is also reported to 
interfere with protein kinase C activity (PKC) (Guler et al., 2011) and suppress 
macrophage iNOS expression and NO production (Proudfoot et al., 1996). Once engulfed, 
Leishmania parasites must evade the oxidative burst in the phagosome and acidic enzymes 
in the phagolysosome released by macrophages to degrade the parasite. Consequently, the 
parasites produce acidic phosphatases to reduce the intensity of the oxidative burst and 
resist the attack of acidic enzymes by maintaining a neutral intracellular pH through a 
proton pump on its surface (Sharma and Singh, 2009). More recently, Leishmania 











in macrophages and immune modulation by parasites (Silva-Almeida et al., 2012). Current 
literature further indicates that Leishmania exosomes are immunomodulatory virulence 
factors responsible for delivery of immunosuppressive Leishmania molecules (such as 
Gp63) to host target cells (Silverman et al., 2010; Olivier et al., 2012). 
1.4.2  Cell mediated host immune responses against L. major 
Experimental infection with L. major in mice defined the Th1/Th2 paradigm of 
resistance/susceptibility to intracellular infection. Resistant C57BL/6 mice develop healing 
Th1 responses with production of IL-12 and IFN-  which upregulate the expression of 
inducible nitric oxide synthase leading to classical activation of macrophages and 
subsequent killing of intracellular parasites by effector NO production (Figure 1.9) 
(Heinzel et al., 1993; Stenger et al., 1994; Guler et al., 1996; Park et al., 2002; Holscher et 
al., 2006). In contrast, lack of healing in susceptible BALB/c mice is associated with a Th2 
response characterized by secretion of IL-4, IL-5, IL-9 and IL-13, high type 2 anti-
Leishmania antibody titres and alternative activation of macrophages (Figure 1.9) 
(Locksley and Scott, 1991; Kopf et al., 1996; Matthews et al., 2000; Iniesta et al., 2002; 
Sacks and Noben-Trauth, 2002; Arendse et al., 2005). Earlier studies demonstrated that 
IFN- deficient mice developed Th2 responses and increased susceptibility to L. major 
infection (Wang et al., 1994). Similarly, genetically resistant C57BL/6 mice lacking IL-12 
displayed increased IL-4 expression and progressive disease to L. major (Mattner et al., 
1996). On the other hand, disruption of the IL-4 gene or treatment with anti-IL-4 
antibodies in susceptible BALB/c mice caused these animals to become highly resistant to 
L. major infection (Sadick et al., 1990; Kopf et al., 1996). Thus, it is now widely accepted 
that IL-4 induces Th2 and inhibits Th1 whereas IL-12/IFN-  induces Th1 and inhibits Th2 
differentiation during cutaneous Leishmaniasis.  
The early IL-4 response to L. major is confined to a population of CD4+ T cells expressing 
a V 4V 8 T cell receptor that recognize the Leishmania antigen LACK (Leishmania 
homologue of receptors for activated C kinase) (Launois et al., 1997). Evidence for this 
comes from the observation that infected V 4-deficient BALB/c mice mount strong Th1 
responses and heal cutaneous lesions (Himmelrich et al., 2000). Both BALB/c and 
C57BL/6 mice secrete IL-4 early after infection, however, production of IL-4 is sustained 
in susceptible BALB/c mice and transient in resistant C57BL/6 mice (Morris et al., 1992; 






























Figure 1.9: Immune responses to L. major in resistant and susceptible mice.  
A. Upon interaction with L. major parasites, activated dendritic cells (DCs) upregulate expression 
of CD40 and produce IL-12 and IL-18. These cytokines interact with the IL-12 receptor 2-chain 
(IL-12R 2) whose expression is increased in activated Th1 cells. Together, a dominant Th1 
response is generated by the production of IFN-  and TNF-  which upregulate the expression of 
inducible nitric oxide synthase (iNOS) and activate infected macrophages for intracellular killing. 
CD8+ T cells and natural killer (NK) cells control infection by producing IFN-  and effector killing 
by macrophages leading to parasite control. B. In contrast, parasite persistence in BALB/c mice is 
due to the failure of an IL-12-dependent redirection of the early Th2 response. This could be due to 
continued expression of early IL-4 from V 4V 8 CD4+ T cells, mast cells and eosinophils at the 
inoculation site and draining lymph nodes, delayed secretion of IL-12 or loss of responsiveness to 
IL-12 due to reduced expression of the IL-12R 2 chain on activated Th2 cells. IL-4 and IL-13 
contribute to susceptibility by suppressing Th1 responses and inhibiting intracellular killing by 
macrophages. This leads to arginase production by macrophages which favor parasite growth. 
Sustained neutrophil recruitment to the site of infection and regulatory T cells promote 
susceptibility and inhibit Th1 responses by the production of IL-10 and TGF- , that inhibit 
activation of macrophages. Solid lines (       ) represent activation and broken lines (       ) represent 
inhibition. Illustration drawn from previous publications (Bogdan et al., 1996; Sacks and Noben-


















It appears that resistant mouse strains redirect the early Th2 response in an IL-12-
dependent mechanism towards a protective Th1 response while in susceptible mice the Th2 
response persists and dominates the disease outcome by suppressing effector mechanisms 
needed for parasite killing (Sypek et al., 1993; Sacks and Noben-Trauth, 2002). This was 
confirmed by the early neutralisation of IL-12, which abrogated resistance in C57BL/6 
mice and led to the production of Th2 cytokines, which selectively inhibited the production 
of nitric oxide by IFN- -activated macrophages (Heinzel et al., 1993; Scharton-Kersten et 
al., 1995). Since IL-12 has been shown to redirect the early Th2 response to L. major and 
promote resistance (Heinzel et al., 1993; Sypek et al., 1993), it suggests that the IL-12 
response is either dysfunctional or inhibited in susceptible BALB/c mice. A loss of IL-12 
signaling due to reduced expression of the IL-12 receptor 2-chain (IL-12R 2) on 
activated Th2 cells has been proposed to explain the defective IL-12 response in BALB/c 
mice (Figure 1.9) (Hondowicz et al., 2000).  
Furthermore, arginase I production in BALB/c induced by Th2 cytokines in alternatively 
activated macrophages has been shown to be essential for Leishmania survival and growth 
(Figure 1.9) (Iniesta et al., 2002). In fact, impairment of alternative macrophage activation 
delays L. major disease progression in susceptible BALB/c mice (Holscher et al., 2006).  
IL-13 (Matthews et al., 2000), IL-9 (Arendse et al., 2005), IL-17 (Lopez Kostka et al., 
2009), IL-10 (Kane and Mosser, 2001), TGF-  (Li et al., 1999), co-stimulatory molecule 
interactions (OX40-OX40L; CD28-B7) (Brown et al., 1996; Akiba et al., 2000), and 
maintenance of inflammatory neutrophils at the site of parasite inoculation (Tacchini-
Cottier et al., 2000) are additional susceptibility factors inducing a persistent Th2 response 
(Figure 1.9). IL-10 suppresses Th1 responses and deactivates macrophages (Figure 1.9) 
(Belkaid et al., 2001; Noben-Trauth et al., 2003) and IL-10-deficient BALB/c mice display 
increased resistance to L. major infection (Kane and Mosser, 2001). Studies have indicated 




) constitute a source of IL-10 that favours the 
persistence of parasites in leishmanial skin lesions (Figure 1.9) (Belkaid et al., 2002a). 
Furthermore, IL-10-producing Tregs also suppress protective immunity and induce 
uncontrolled parasite growth in L. major-infected BALB/c mice (Xu et al., 2003). Thus, 
IL-10 and Treg cells are important regulators of resistance/susceptibility to cutaneous 
Leishmaniasis.  
IFN- -induced NO production by classically activated macrophages is crucial for the 












infection (Wei et al., 1995). In addition to IFN-  and IL-12, other protective mediators 
assist in the regulation of Th1 development and parasite clearance during L. major 
infection. Specifically, C57BL/6 mice genetically deficient for Th1 transcription factor T -
bet (Szabo et al., 2002), STAT4 (Stamm et al., 1999), TNF (Wilhelm et al., 2001) or 
CD40-CD40L interactions (Campbell et al., 1996; Kamanaka et al., 1996) show an 
increased susceptibility to infection. IL-18 augments IL-12 activity (Yoshimoto et al., 
1998) and protects against L. major infections (Monteforte et al., 2000). IL-12 activates 
innate natural killer cells and CD8
+
 T cells to produce IFN- , which in turn contributes to 
Th1 responses by increasing expression of the IL-12R by activated Th1 cells and activating 
macrophages for intracellular killing (Figure 1.9) (Scharton-Kersten et al., 1995; Belkaid et 
al., 2002b). Collectively, it appears that IL-12 and the other Th1-promoting factors redirect 
the early IL-4/Th2 responses to L. major infection in resistant mice. However, IL-12/IL-
12R signaling remains crucial to a healing Th1 response and IL-4 remains central to a non-
healing Th2 response.  
1.5  Dendritic cells and macrophages in L. major infection 




 T cells to 
induce protective immunity against L. major infection (Reiner and Locksley, 1995). Since 
Leishmania infect macrophages, early studies focused on macrophages as the source of IL-
12. However, it was found that macrophages from both susceptible and resistant strains of 
mice made very little IL-12 in response to Leishmania promastigotes and the parasite was 
in fact able to inhibit IL-12 secretion by macrophages (Reiner et al., 1994; Carrera et al., 
1996; Belkaid et al., 1998). In contrast to macrophages, DCs play an important role in 
secreting IL-12 and subsequently orchestrating Th1 cell differentiation and protective 
immunity to Leishmania infection (Liu and Uzonna, 2012). Leishmania-infected 
macrophages also secrete immuno-regulatory cytokines such as IL-10 and TGF- which 
inhibit their killing capacity and promote susceptibility (Alexander et al., 1999; Belkaid et 
al., 2001) whilst IFN- , IL-1, TNF-  and type I interferons activate macrophages and 
enhance its leishmanicidal activity (Wang et al., 1994; Diefenbach et al., 1998; Von Stebut 
et al., 2003).  
Macrophages can phagocytose L. major via the CR3 receptor (Mosser and Edelson, 1985) 
or through Fc receptors with IgG-coated parasites (Liu and Uzonna, 2012). CR3-mediated 











1993) whilst C-type lectin, Fc  and Toll-like receptors have been implicated in the 
ingestion of promastigotes by DCs (Colmenares et al., 2004; Woelbing et al., 2006; Tuon 
et al., 2008). Whilst both macrophages and DCs are considered major APCs and present 
antigen via the MHC Class II pathway, only DCs can prime and stimulate L. major specific 
CD8
+
 T cells via the MHC Class I pathway (Belkaid et al., 2002b; Woelbing et al., 2006). 
Moreover, L. major suppresses MHC Class II presentation of parasite and non-parasite 
antigen to CD4
+
 T cells in infected macrophages, possibly as a ploy to evade detection by 
the adaptive immune system (Fruth et al., 1993). Importantly, DCs and not macrophages, 
can be used to vaccinate against Leishmaniasis in vivo (Flohe et al., 1998; Ahuja et al., 
1999; von Stebut et al., 2000) whilst macrophages and not DCs are the major effector cells 
responsible for destruction of Leishmania parasites. Thus, although DCs and macrophages 
are ontogenetically related, they play distinctly different roles in the initiation and 
propagation of immune responses against Leishmania parasites. 
1.5.1  Interaction of dendritic cell subsets with L. major parasites 
Various studies have indicated that different DC subsets respond differently to infection by  
Leishmania parasites. Murine epidermal Langerhans cells were found to be the first subset 
of dendritic cells to phagocytose L. major amastigotes, but not promastigotes, in the skin 
and secrete IL-12 (Moll, 1993; von Stebut et al., 1998). Parasite uptake was associated 
with an increase in DC activation as shown by the upregulation of surface expression of 
MHC Class I and Class II and co-stimulatory molecules (Liu and Uzonna, 2012). 
Langerhans DCs were initially thought to transport parasite antigen from the infected site 
to the draining lymph node for presentation to antigen-specific T cells (Blank et al., 1993; 
Moll et al., 1993). However, new evidence suggests that although dermal Langerin- DCs 
and LC DCs may transport L. major antigens to the draining lymph node, only dermal DCs 
activate CD4
+
 T cells (Ritter et al., 2004). Follow-up studies demonstrated that mice 
lacking MHC Class II antigens exclusively on LCs, and not dermal DCs, were able to 
control L. major infection confirming that LCs are dispensable for triggering T cell 
responses during Leishmania infection (Lemos et al., 2004). Moreover, a recent study has 
indicated that LCs may even play a pathogenic role during low-dose L. major infection due 
to their induction and expansion of Tregs (Kautz-Neu et al., 2011b). 
Plasmacytoid DCs are also detected in the infected skin and are activated by Leishmania 
DNA to secrete IL-12 and increased levels of IFN- / which have been shown to induce 











derived dendritic cells (mDCs) are also recruited to the site of infection. mDCs can 
efficiently engulf parasites and secrete early IL-12 and pro-inflammatory cytokines 
(Konecny et al., 1999; Soong, 2008). Activated mDCs have been implicated in stimulating 
NK cells and inducing a more powerful parasite-specific IFN- -mediated Th1 response 
(Leon et al., 2007). CD40-CD40L interactions and exogenous stimuli such as IL-1, IFN- , 
IFN- /LPS were also shown to enhance DC-derived IL-12 production during infection 
(Campbell et al., 1996; Kamanaka et al., 1996; von Stebut et al., 2000). TLR9-dependant 
activation of DCs by Leishmania DNA is also reported to be involved in protection to L. 
major infection (Abou Fakher et al., 2009). Murine lymphoid DCs in the spleen also differ 
in their ability to phagocytose amastigote parasites with CD8
+
 DCs being the least 
permissive to amastigotes compared to CD8
-
 DCs. However, CD8
+
 DCs are the best 
producers of IL-12p70 in response to infection (Henri et al., 2002).  
It has also been reported that antibody opsonisation of Leishmania enhances uptake of the 
parasites by Langerhans cells and monocyte-derived DCs, which is associated with 
increased IL-10 release. DCs that have taken up opsonised Leishmania preferentially prime 
IL-10-producting CD4
+
 T cells, thus contributing to increased susceptibility to infection 
(Soong, 2008). In contrast, other studies have demonstrated that uptake of antibody-
opsonized parasites activates mDCs to secrete IL-12 and induce protective immunity. 
These different findings indicate that antibodies do play a regulatory role in cutaneous 
Leishmaniasis to mediate different effector responses (Soong, 2008).  
Some studies have speculated that the different DC responses to Leishmania parasites may 
be attributed to genetic resistance or susceptibility of mice to infection. Whilst some 
studies have shown that DCs from both susceptible and resistant mice exhibit comparable 
upregulation of MHC, co-stimulatory molecules and release of IL-12p70 (von Stebut et al., 
1998), other studies have demonstrated increased IL-4 receptor and down-regulation of 
CD40 and IL-12p40 expression on DCs from BALB/c but not resistant C57BL/6 mice 
(Heinzel et al., 1998; Mbow et al., 2001; Moll et al., 2002). Overall, it may seem that 
Leishmania parasites have developed strategies to inhibit DC-mediated Th1 responses in 
susceptible mice. However, more studies need to be conducted to provide clear evidence if 
the observed differences in DCs between susceptible and resistant mice contribute to 












1.5.2  Evasion of L. major parasites from dendritic cell presentation 
Leishmania parasites also modulate and impair DC functions to escape the host immune 
system and establish infection. Products secreted by L. major promastigotes have been 
shown to inhibit the motility of murine splenic DCs (Jebbari et al., 2002) whilst migration 
of L. major infected murine Langerhans cells is inhibited by LPG (Ponte-Sucre et al., 
2001). Leishmania parasites can modulate chemokine receptor expression, such as CCR2 
and CCR5 on DCs, which may contribute to this inhibition of DC motility (Steigerwald 
and Moll, 2005). Moreover, absence of CCR2 leads to increased susceptibility to L. major 
infection, dominated by Th2 cytokines (Sato et al., 2000).  Overall, this suggests that 
Leishmania parasites have the ability to interfere with DC transportation of antigen to or 
within lymphoid tissue and thus, further delay the onset of acquired immunity. 
Further studies have demonstrated that Leishmania parasites hinder the onset of adaptive 
immunity by delaying DC maturation/activation in order to allow establishment of 
infection (Moll et al., 1995). Moreover, L. major infected murine CD11c+ lymph node DCs 
maintain high parasite loads owing to reduced MHC Class II antigens and no detectable 
CD86 expression (Muraille et al., 2003). LPGs of L. major promastigotes impair the 
induction of Th1 responses by down-modulating DC-derived IL-12 production (Liu et al., 
2009). Epidermal Langerhans DCs from susceptible BALB/c mice also down-regulate IL-
12p40 expression in response to L. major infection (Moll et al., 2002). DCs are also 
modulated by IL-10 production during Leishmania, infection which generally tends to 
favor Th2 responses by inhibiting Th1 responses.  
1.5.3  Immunobiology of human cutaneous Leishmaniasis and dendritic cell interactions  
L. major infection in resistant strains of mice resembles self-limiting cutaneous 
Leishmaniasis in humans (Sharma and Singh, 2009). However, in human L. major 
infection, a distinct dichotomy in the T cell response against Leishmania parasites is not 
clearly evident as demonstrated in murine models. Generally, a mixed Th1/Th2 cytokine 
response is seen in patients with cutaneous Leishmaniasis (Ajdary et al., 2000), however, 
IL-13, IL-4, IL-10 and TGF-  have been detected in the skin after initial infection 
suggesting that Th2 cytokines play an immunoregulatory role in human cutaneous 
Leishmaniasis (Melby et al., 1994; Ajdary et al., 2000).  Nonetheless, clearance of 
infection still depends on IL-12 induced IFN-  production (Kolde et al., 1996).  Myeloid-
derived human dendritic cells secrete IL-12p70 in conjunction with CD40-CD40L 











promastigotes results in DC maturation and upregulation of HLA-DR and co-stimulatory 
molecules. Human DCs also respond well to antibody-opsonised parasites in vitro and 
secrete IL-12 upon activation mimicking the in vivo infection (Sharma and Singh, 2009). 
1.6  IL-4R  signaling in cutaneous Leishmaniasis 
Recently, IL-4R  signaling has been investigated for its intriguing role in affecting the 
outcome of various parasitic infectious diseases such as cutaneous Leishmaniasis (Mohrs 
et al., 1999), acute Schistosomiasis (Mountford et al., 2001; Herbert et al., 2004; Dewals et 
al., 2009) and nematode infections (Urban et al., 1998; Horsnell et al., 2007; Schmidt et 
al., 2012). Both IL-4 and IL-13 can signal through the IL-4R  chain therefore deletion of 
the IL-4R  impairs downstream signaling of both IL-4 and IL-13 responses via 
trancription factor STAT6. This has been established in animal studies during L. major 
infection in which susceptible BALB/c mice deficient for IL-4 (Kopf et al., 1996), IL-13 
(Matthews et al., 2000) or STAT6 (Stamm et al., 1998) were able to control disease 
progression.  
Initial control of L. major during the acute phase of infection in IL-4-/- and IL-4R -/- 
deficient BALB/c mice is equivalent, with both strains of mice showing reduced footpad 





 mice developed progressive disease and necrotic footpad 
lesions during the chronic phase of infection. In contrast to IL-4
-/-
 mice, the absence of IL-
13-mediated functions in IL-4R
-/-
 mice implicated IL-13 as a susceptibility factor in 
chronic L. major infection (Mohrs et al., 1999). Furthermore, IL-13 transgenic C57BL/6 
mice were shown to develop a susceptible phenotype to acute Leishmaniasis with impaired 
IL-12 and IFN-  production, while IL-13-deficient BALB/c mice remained comparatively 
resistant (McKenzie et al., 1998b; Matthews et al., 2000). IL-13 promotes susceptibility by 
activating IL-4/IL-13 alternative macrophages and suppressing secretion of NO, IL-12 
and/or IL-18 (McKenzie et al., 1998b; Matthews et al., 2000).  
The role of IL-4 and IL-4R  in Leishmania infection mice is controversial since 
conflicting reports have suggested that although IL-4 is important, it is not the sole 
mediator of susceptibility in BALB/c mice. Whilst Kopf et al. (1996) and Mohrs et al. 




 mice were able to control acute 
Leishmaniasis, Noben-Trauth et al. (1996) showed that IL-4-/- and IL-4R -/- deficient 











discrepancy between the two studies could be attributed to the use of parasite substrains of 
different virulence which may have affected the outcome of L. major infection in IL-4-/- 
and IL-4R
-/-
 BALB/c mice. Important to note from either of the studies mentioned above 
is that even in the absence of IL-4 or IL-4R , Th2-cell development and Th2-related 
cytokines were still present, albeit in different Th1/Th2 ratios (Kopf et al., 1996; Noben-
Trauth et al., 1996; Noben-Trauth et al., 1999). To address the conflicting issues on the 
role of IL-4 in Th2-cell development and Th2-cytokines during L. major infection, 
subsequent studies followed IL-4 expression and T helper cell development in vivo in L. 
major-infected IL-4R -/- deficient BALB/c mice. This study confirmed that IL-4R -
independent mechanisms underlie the default Th2 pathway in L. major-infected BALB/c 
mice because despite a clear absence of IL-4/IL-13-mediated functions in IL-4R
-/-
 
deficient mice, unimpaired Th2 polarization and IL-4-producing CD4
+
 T cells as well as 
other Th2-related cytokines were still present (Mohrs et al., 2000) Similar findings were 
also reported for IL-4
-/-
 deficient BALB/c mice (Noben-Trauth et al., 1997; Kropf et al., 
1999). Together, these findings contradict the idea that IL-4 is the sole regulator of 
susceptibility to L. major infection. The accumulating reports instead suggest that both IL-
4-dependent and IL-4-independent factors contribute to the susceptibility phenotype in L. 
major-infected BALB/c mice (Brombacher, 2000). 
Given the conflicting data on IL-4R  signaling in the outcome of L. major infection, 
several studies have aimed to clarify the role of IL-4R -signaling in specific cell 
populations in resistance or susceptibility to infection. Given the central role of T cells in 
L. major infection (Scott et al., 1988) and controversial roles of IL-4 (Kopf et al., 1996; 
Noben-Trauth et al., 1996), specific abrogation of IL-4R  on CD4+ T cells (with variable 
deletion on CD8
+




 BALB/c mice was investigated during L. 
major infection. Lack of IL-4R  signaling on CD4
+
 T cells led to a healing phenotype in 
BALB/c mice (Radwanska et al., 2007). Resistance to L. major in LckcreIL-4R -/lox 
BALB/c mice was higher than in global IL-4R
-/-
 mice and was associated with early IL-
12 mRNA induction which led to increased IFN-  production, elevated iNOS expression 
and increased DTH responses, similar to genetically resistant C57BL/6 mice. This 
demonstrated that impairment of IL-4R -dependent CD4
+
 Th2 cells in the presence of IL-
4/IL-13-responsive non-CD4
+











phenotype, indicating a beneficial role for IL-4R  signaling on other cell types in 
cutaneous Leishmaniasis.  
In another study, Holscher and colleagues analysed IL-4R  signaling on 
macrophages/neutrophils in L. major-infected LysMcreIL-4R -/lox BALB/c mice (Holscher 
et al., 2006). Their study revealed that the absence of IL-4R  on macrophages (and 
neutrophils) significantly delayed disease progression, although Th2 and type 2 antibody 
immune responses were similar to littermate controls. These data revealed that IL-4R -
mediated effects on macrophages are involved in the development of early disease 





 BALB/c mice was attributed to inhibition of alternative activation of 
macrophages, leading to classical activation of macrophages, with enhanced NO 
production and decreased arginase activity. These data reinforced that alternatively 
activated macrophages enhance susceptibility to cutaneous Leishmaniasis. Since it is 
known that IL-4R  engagement suppresses IL-12 production in macrophages (Herbert et 
al., 2004), the authors postulated that IL-4R  deficiency on macrophages and neutrophils 
could have led to IL-4R -dependant protective mechanisms involving other phagocytic 





 BALB/c mice. This proposal is especially reasonable given the fact that 
dendritic cells have been implicated in Th1 cell development owing to the newly coined 
“IL-4-mediated DC instruction” theory. 
1.6.1  IL-4-mediated dendritic cell instruction in cutaneous Leishmaniasis 




 BALB/c mice remained susceptible to L. major (Noben-
Trauth et al., 1999) challenged the prevailing view that IL-4 and IL-4-producing Th2 cells 
are antagonists of Th1 immune responses. Although some studies have clearly shown IL-4 
to be the primary inducer of Th2 responses (Sadick et al., 1990; Himmelrich et al., 2000), 
paradoxically other studies have also shown that IL-4 can promote Th1 development and 
the initiation of protective immunity. IL-4 was shown to promote IL-12 production by 
bone-marrow derived dendritic cells (BMDCs) stimulated with CpG or lipopolysaccharide 
(LPS) (Hochrein et al., 2000; Biedermann et al., 2001; Lutz et al., 2002). Furthermore, 
administration of 1 g of recombinant IL-4 at 0 and 8 hours after infection in BALB/c 
mice with L. major led to increased IL-12 mRNA expression by dendritic cells (DCs) in 











additional injections of recombinant IL-4 during the period of T cell priming, which occurs 
12–16 h after parasite inoculation, abrogated the resistance induced by IL-4 during the first 
8 h and induced Th2 differentiation and progressive disease (Biedermann et al., 2001). 
This study provided a new paradigm for the mode of action of IL-4 and gave rise to the 
“IL-4-mediated dendritic cell instruction” theory. 
The IL-4 instruction theory suggests that IL-4 acting on DCs during DC activation 
instructs them to produce IL-12, resulting in the polarisation of naïve T cells into Th1 cells, 
and enhancing control of Leishmania infection. On the other hand, IL-4 present during the 
period of T cell priming polarises naïve T cells towards a Th2 phenotype, resulting in 
continued production of Th2 cytokines and parasite persistence (Figure 1.10). Early 
sources of IL-4 include V 4V 8 CD4
+
 T cells, mast cells, eosinophils and basophils. 
Therefore, it appears that the outcome of disease in L. major infected BALB/c mice 
depends on the timing of IL-4 interacting with different cell types. Naturally, IL-4R  
expression on DCs and naïve T cells is central to this instruction for signaling the IL-4 to 
exert its downstream effects on the immune response. 
A follow-up study demonstrated that IL-4-mediated DC instruction is dependent on IL-10 
since IL-4 treatment of DCs stimulated with LPS or CpG suppresses IL-10 production 
resulting in enhanced IL-12 secretion (Figure 1.10). Furthermore, the authors found that 
IL-4 inhibited IL-10 production only in DCs but not other APCs, such as B cells, and failed 
to up-regulate IL-12 production in IL-10-deficient DCs (Yao et al., 2005). IL-4 could 
potentially exert its effects on dendritic cells using either or both of the Type I and Type II 
IL-4R  receptor complexes (Lutz et al., 2002). However, experiments in BMDCs 
demonstrated that enhancement of IL-12 production depends exclusively on the Type I IL-
4R complex and IL-4 in vitro. IL-4 and IL-13-mediated maturation of DCs occurs via the 
Type II IL-4R complex (Lutz et al., 2002). IL-13 is unable to signal via the Type I IL-4R 
complex and has been shown not to enhance BMDC-derived IL-12 production (Lutz et al., 
2002; Masic et al., 2012). However it was found that both IL-4 and IL-13 enhanced 
maturation of BMDCs, via the Type II IL-4R complex. The ability of IL-4 to instruct IL-12 
production by dendritic cells, enhancing Th1 responses, suggests that IL-4R  signaling on 
DCs could play a role in resistance to L.major infection.  
Although IL-4-mediated DC instruction of Th1 immunity is the most investigated role of 











DCs could promote Th2 responses. Since there is little evidence to suggest that DCs 
themselves secrete IL-4 to favor Th2 differentiation, other DC-derived factors have been 
proposed to aid the process, for instance, secretion of Th1 inhibiting cytokines, IL-10 and 
TGF- , increased secretion of IL-6 (Rincon et al., 1997) or upregulation B7-1 and B7-2 
costimulatory molecules (Moser and Murphy, 2000). Recently, a study demonstrated a 
direct role for IL-4R -signaling of IL-4 on DCs in the development of alternatively 
activated DCs that prime optimal Th2 responses to S. mansoni antigens (Cook et al., 2012). 
Altogether, the general hypothesis on IL-4 signals on DCs contributing to Th2 
development is that the Th2 pathway may occur as the default pathway in the absence of 
















Figure 1.10: The “IL-4-mediated dendritic cell instruction” theory 
Biedermann and colleagues reported a paradox wherein IL-4 can promote both Th1 and Th2 
responses in BALB/c mice. If early IL-4 is administered early during the period of dendritic cell 
(DC) activation, it instructs DCs to produce IL-12 which leads to a polarised Th1 response and 
parasite control. Increased IL-12 production was shown to be due to a decrease in 
immunosuppressive IL-10 production, mediated by IL-4R  signaling. However, if IL-4 is present 
during the period of T cell priming, IL-4 in the microenvironment of cells induces naïve T cells to 
differentiate into Th2 cells resulting in an environment that favours parasite persistence. Early 
sources of IL-4 could include V 4V 8 CD4+ T cells, mast cells, eosinophils and/or basophils. IL-













1.7  Generation of dendritic cell-specific IL-4R  deficient mice using the Cre/loxP 
system 
In order to determine the effects of IL-4R  signaling through dendritic cells in L. major 




 BALB/c mice, in which dendritic-cell specific 
deletion of the il4ra gene was achieved by the bacteriophage derived Cre/loxP 
recombination system under control of the cd11c locus (Figure 1.11) (Caton et al., 2007). 
In this system, cyclization recombinase (Cre) inserted downstream of the cell-specific 
promoter recognizes a pair of loxP sequences flanking the gene of interest (Exon 7 to Exon 
9 of IL-4Rα). Cre-recombinase removes the intervening DNA by bringing the two loxP 
sites together (Nagy, 2000). CD11c encodes the integrin alpha X chain which is a 
transmembrane protein typically expressed on DCs and alveolar macrophages (Banchereau 
et al., 2000). CD11c is mainly involved in phagocytosis but other diverse roles in antigen-
presentation, inflammation, innate immunity and tissue homeostasis have also been 
described (Sadhu et al., 2007). Generation of CD11ccreIL-4R -/- BALB/c mice is 
illustrated in Figure 1.11. Transgenic CD11c
cre
 mice w re backcrossed to BALB/c for 9 
generations, then intercrossed with global IL-4R  (IL-4R
-/-





 BALB/c mice. Littermate mice were then subsequently intercrossed 
with floxed IL-4R  (IL-4R
lox/lox
) BALB/c mice (Exon 6 to Exon 8 flanked by loxP) 
(Herbert et al., 2004) to yield CD11ccreIL-4R -/lox BALB/c mice (Hurdayal, and 
Nieuwenhuizen, et al. Submitted manuscript). A similar approach using the Cre/loxP 


















) (Herbert et al., 2004; Horsnell et al., 2007; 
















































 BALB/c mice.  
Global IL-4Rα-/- BALB/c mice were intercrossed with transgenic BALB/c mice expressing Cre-
recombinase under control of the CD11c locus. Littermate mice (F2) were then crossed with IL-
4Rαlox/lox mice to generate CD11ccreIL-4R -/lox BALB/c mice. The “floxed” IL-4Rα allele (yellow 
arrows) and deleted allele (red arrows) are shown. In cells where the CD11c promoter is 
recognised, IL-4R  is deleted and the functions of IL-4/IL-13 through the receptor are impaired. In 


































1.8  Hypothesis and research objectives  
In this study, we investigate the role of IL-4R  signaling on dendritic cells during L. major 
infection in vivo. Most studies on the effects of IL-4 and IL-13 on DCs were conducted 
using in vitro BMDC cultures and thus the in vivo effects of IL-4R  signaling on DCs 
during acute cutaneous Leishmaniasis are unknown. Therefore, we created dendritic cell 




) by cell-specific gene 
targeting using the Cre-loxP system (Figure 1.11). We hypothesized that IL-4R  signaling 
of IL-4 on DCs is important in instructing optimal Th1 responses and subsequent control of 
acute cutaneous L.major infection. Our objectives were as follows: 
 
(A) To investigate whether IL-4-mediated dendritic cell instruction occurs in cutaneous 
Leishmaniasis in  vivo using CD11ccreIL-4R -/lox BALB/c mice. 
(B) To establish whether dendritic cell-specific deletion of IL-4R  affects the outcome 
of acute L. major infection in CD11ccreIL-4R -/lox BALB/c mice by determining 
parasite burdens, cellular and humoral immune responses and macrophage effector 







































































MATERIALS AND METHODS 




 BALB/c mice.  




) BALB/c mice were 
generated and characterized by our laboratory (Hurdayal and Nieuwenhuizen et al. 
Submitted manuscript). Briefly, CD11c
cre
 mice (Caton et al., 2007) were crossed with IL-
4R
lox/lox
 BALB/c mice (Herbert et al., 2004) and complete IL-4R -/- BALB/c mice 
(Mohrs et al., 1999) to generate hemizygous CD11ccreIL-4R -/lox BALB/c mice. 
Hemizygous littermate controls (IL-4R
-/lox
) were used as controls in cutaneous 
Leishmaniasis experiments together with wild type (WT) BALB/c mice and global IL-
4R
-/-
 BALB/c mice. C57BL/6 mice were used as resistant control mice in the L. major 





BALB/c mice. Mouse genotyping was performed by Wendy Green 
and Rayaana Fredericks at the Division of Immunology.  




 BALB/c mice 
Gene Target Primer 
WT IL-4R Forward 5' TGACCTACAAGGAACCCAGGC 3' 
WT IL-4R Reverse 5' CTCGGCGCACTGACCCATCT 3' 
Deletion IL-4R Forward 5' GGCTGCTGACCTGGAATAACC 3' 
Deletion IL-4R Reverse 5' CCTTTGAGAACTGCGGGCT 3' 
LoxP – Forward  5' GGCTGCTGACCTGGAATAACC 3' 
LoxP – Reverse  5' GTTTCCTCCTACCGCTGATT 3' 
Cre – Forward  5' ATGCCCAAGAAGAAGAGGAAGGT 3' 
Cre – Reverse  5' GAAATCAGTGCGTTCGAACGCTAGA 3' 
 
All mice were housed in specific-pathogen free barrier conditions in individually ventilated 
cages at the University of Cape Town, South Africa. Mice were age and sex matched and 
used between 8-12 wks of age. This study was performed in strict accordance with the 
recommendations of the South African National Guidelines and University of Cape Town 
of practice for laboratory animal procedures. All mouse experiments were performed 











Sciences Faculty, University of Cape Town (Permit Number: 009/042). All efforts were 
made to minimize suffering of the animals.  
2.2  IL-4R  responsiveness in bone marrow-derived dendritic cells (BMDCs) 
Bone marrow-derived dendritic cells (BMDCs) were generated from bone marrow 
progenitors using mouse granulocyte-macrophage colony-stimulating factor (GM-CSF) 
(Sigma-Aldrich) as previously described (Lutz et al., 1999). 





 and littermate control mice. Cells (2 × 10
6
) were cultured for 10 days in sterile Petri 
dishes with complete Roswell Park Memorial Institute (RPMI) (Sigma-Aldrich) medium 
containing 10% fetal calf serum (FCS) (Gibco Life Technologies, Paisly, UK), 100 
units/ml penicillin plus 100 g/ml streptomycin (Invitrogen Life Technologies), 2 mM L-
glutamine, 1 mM sodium pyruvate, 1% -mercaptoethanol (Sigma-Aldrich) 200 U/ml GM-
CSF or 50% GM-CSF-rich supernatant generated by NIH3T3 cells. On Day 10, non-
adherent cells were harvested and 5 × 10
5
 BMDCs were stimulated with LPS (Sigma-
Aldrich; 1 g/ml) or Leishmania major IL-81 promastigotes (MOI: 10 parasites/cell) in the 
presence or absence of 1000 U/ml recombinant mouse IL-4 or IL-13 (rIL-4/rIL-13, BD 
Biosciences) for 48 hrs. Following incubation, IL-12p40, IL-12p70 and IL-10 cytokines 
were measured in culture supernatants by ELISA. 
2.3  Leishmania major infections 
L. major LV39 (MRHO/SV/59/P) (Mattner et al., 1996), L. major IL81 
(MHOM/IL/81/FEBNI) and GFP-expressing L. major IL81 (MHOM/IL/81/FEBNI) (kind 
gift from Prof. Heidrun Moll, University of Würzburg, Germany) strains were maintained 
by continuous passage in susceptible BALB/c mice. Parasites were harvested from footpad 
skin lesions and popliteal lymph nodes of infected animals and cultured in vitro in 10 ml 
Schneiders medium (Sigma-Aldrich) supplemented with 20% FCS in a tissue culture flask 
(Corning). After 7 days in a humidified chamber at RT (stationary growth phase), the 
parasites were fixed in 2% gluteraldehyde, enumerated on a Neubauer cytometer slide and 
prepared for infection studies. Prior to infection, experimental mice were randomly 
selected but were age and sex matched and used between 8-12 weeks of age. Anaesthetised 




 stationary phase metacyclic 
promastigote parasites into the left hind footpad in a volume of 50 l of Hank’s Balanced 











unblinded, using a Mitutoyo micrometer caliper (Brütsch, Zürich, Switzerland). Mice 
infected with L. major LV39 were sacrificed at either 3 or 8 weeks after infection whilst 
mice infected with the virulent IL81 strains were sacrificed at 4 weeks after infection (see 
Appendix A for additional reagents for all experiments). 
2.4  Quantification of viable L. major parasite burden 
Quantification of viable parasite burden was determined by the limiting dilution method 
(Mohrs et al., 1999). The infected footpad was collected in 2 ml Schneiders medium 
supplemented with 20% FCS whilst popliteal lymph nodes, spleens, livers and brains were 
collected in 2 ml complete Dulbecco's Modified Eagle's Medium (DMEM, Gibco) 
supplemented with 10% FCS, 100 units/ml penicillin, 100 g/ml streptomycin, 50 M -
mercaptoethanol and 1% HEPES (Invitrogen Life Technologies). Spleens were weighed 
after being removed from infected animals. Footpads, spleens, livers and brains were 
homogenised and lymph nodes were pressed through a 70 M strainer to obtain single cell 
suspensions in a final volume of 6.4 ml (100 l = 2
6 
parasites). Two-fold serial dilutions 
were prepared in 96 well flat-bottom plates using Schneider’s media with 20% FCS in a 
final volume of 100 l. After 7 days incubation at RT, each individual well was examined 
and scored microscopically for the presence of parasite growth. Prior to removal of mouse 
brain tissue for detection of parasite burden, animals were perfused with 20 ml sterile 
saline solution. Detection of viable parasite burden was estimated as previously described 
(Mohrs et al., 1999).  
2.5  Isolation and stimulation of lymph node cells 
Lymph nodes from infected mice were collected in complete DMEM containing 10% FCS 
(Gibco Life Technologies, Paisly, UK), 0.05 mM -mercaptoethanol (Sigma-Aldrich, 
Deisenhofen, Germany), penicillin (100 U/ml) and streptomycin (100 µg/ml) (Gibco). 
Single cell suspensions were prepared by pressing draining lymph nodes through a 70 M 
cell strainer (Falcon, New Jersey, USA) followed by centrifugation at 1300 rpm for 5 min 
at 4
o
C. Pelleted cells were resuspended in 5 ml complete DMEM and viable cells 
enumerated by Trypan Blue exclusion (Sigma-Aldrich). Cell were then cultured in 
triplicates at 1 × 10
6 
/ml in 48- CD3 (100 g/ml) or soluble L. major-
antigen (SLA, 50 g/ml) and incubated at 37
o
C and 5% CO2. Supernatants were removed 












2.6  Isolation and antigen-specific restimulation of CD4
+
 T cells 
CD4
+
 T cells from total lymph node cell suspensions (described above) were positively 
selected using anti-CD4 microbeads (MACS, Miltenyi Biotec), according to the 
manufacturer’s instructions. Briefly, total lymph node cells were incubated with anti-CD4 
microbeads and passed through an LS separation column. The magnetically labelled CD4 
cells remain bound to the column whilst unlabelled cells flow through. Following washing 
3×, the columns were removed from the magnetic field and viable CD4
+
 cells were 
counted using Trypan Blue exclusion (Sigma-Aldrich) to a purity of >95%, as confirmed 
by FACS analysis. Individual spleens were collected from either WT BALB/c or C57BL/6 
mice into 5 ml complete DMEM. Single cell suspensions were prepared by pressing 
spleens through a 70 µm cell strainer (Falcon, New Jersey, USA) followed by 
centrifugation at 1300 rpm for 5 min at 4
o
C. Splenocytes were depleted of RBCs by 
hypotonic lysis in Red Cell Lysis Buffer (see Appendix A) followed by centrifugation at 
1300 rpm, 5 min at 4
o
C. Pelleted cells were incubated with anti-Thy1.2 for 30 min at 4
o
C. 
After washing, splenocytes were incubated with rabbit serum (1:5) for 30 min at 37
o
C to 
allow T cell depletion of Thy1.2-labeled splenocytes by complement-mediated lysis 
thereby enriching antigen-presenting cells (APCs) in suspension. APCs were then treated 
with 50 μg/ml mitomycin C (Sigma-Aldrich) for 20 min at 37
o
C and washed extensively in 
complete DMEM. Cells were resuspended in 2 ml complete DMEM and stained with 




 T cells 
and 1×10
5 
APCs were cultured with soluble Leishmania antigen (50 μg/ml). After 72 hrs 
incubation at 37
o
C and 5% CO2, supernatants were collected and cytokine production was 
analysed by ELISA (see Appendix A for additional reagents for all experiments). 
2.7  Isolation of footpad and spleen cells 
Footpads and spleens of infected mice were collected in DMEM containing 2% 
Penicillin/Streptomycin. Muscle tissue was separated from infected footpads and digested 
in DMEM medium containing 2% Penicillin/Streptomycin supplemented with Collagenase 
IV (Sigma-Aldrich; 1 mg/ml) and DNase I (Sigma-Aldrich; 1 mg/ml) at 37
o
C and 5% CO2 
for 60 min. Following incubation, Collagenase IV activity was stopped by adding an equal 
volume of DMEM supplemented with 10% FCS. Single cell suspensions were isolated by 
pressing footpad tissue through 40 M cell-strainers into 50 ml Falcon tubes (Corning). 
Spleen cells were isolated by pressing through 70 M cell-strainers and depleted of RBCs 













C. Pelleted cells were washed, resuspended in 10 ml complete DMEM and stained 
with Trypan Blue (Sigma-Aldrich) to count viable cells.  
2.8  Flow cytometry 
Total lymphocytes, splenocytes and footpad cells were isolated as described above, 
resuspended in FACS buffer and transferred into FACS tubes for staining. Cells were 
centrifuged at 1500 rpm for 5 min at 4
o
C. Cell pellets were stained in 50 l antibody mix 
containing 1% heat-inactivated rat serum and 10 ug/ml anti-FcR. The anti-FcR (clone: 
2.4G2) was used in order to block non-antigen-specific binding of immunoglobulins to the 
FcγII and FcγIII receptors. Cells were resuspended in antibody mix and incubated for 20 
min at 4
o
C. Unbound antibody was removed by washing and centrifugation at 1500 rpm 
for 5 min at 4
o
C. Finally, stained cells were resuspended in 300 l FACS buffer for 
acquisition. Expression of surface markers on cell populations were identified using 
fluorescein isothiocyanate (FITC), phycoerythrin (PE) or biotinylated mAbs against:  
SiglecF-PE (clone E50-2440), CD11c-PE or APC (clone HL3), MHCII-biotin (clone 
M5/114), F4/80-PE (clone: A3-1), anti-CD124-PE, CD3-FITC/PerCP (clone 145-2C11), 
CD19-PE (clone 1D3), CD11b-FITC or PE (clone M1/70), CD4-PerCP (clone GK1.5), 
CD103-Biotin (clone M290), CD8-PE (clone: 53.6.72), GR-1-PE (clone RB68C5), rat 
anti-mouse IgG2a-PE, CD11c-biotin (clone HL3) and rat-anti mouse IgG2a biotin (all BD 
Bioscience, Erembodegem, Belgium), PDCA-APC (clone JF05-IC2.4.1) and SiglecH-PE 
(clone 551.3D3) (R&D Systems). Biotin-labelled antibodies were detected by staining with 
either streptavidin-allophycocyanin (APC) or streptavidin-peridinin chlorophyll protein 
(PerCP). For intracellular cytokine staining, popliteal lymph node cells from L.  major 
infected mice were isolated as described above and seeded at 2 × 10
6
 cells/well in 96 well 
V-bottom plates (Nunc). Cells were stimulated at 37
o
C for 4 hours in complete DMEM 
with phorbal myristate acetate (Sigma-Aldrich) (50ng/ml) and ionomycin (Sigma-Aldrich) 
(250 ng/ml) as well as monensin (200 M) (Sigma-Aldrich), which was added to 
accumulate expressed cytokins. Dendritic cells were identified by staining with CD11c PE-
Cy7 (BD Bioscience, clone N418) and MHCII APC (BD Bioscience, clone M5/114). 
Following staining, cells were washed and fixed in 2% paraformaldehyde for 20 min at 
4
o
C. Following washing, staining and fixation, cells were permeabilized with 
Permeabilization buffer for 30 min at 4
o
C. Intracellular cytokines were stained with anti-
IL-10 (clone JES5-16E3), anti-IL-12 (clone C15.6) and isotype controls (BD Bioscience) 











Immunocytometry systems, San Jose, CA, USA) and data were analyzed using Flowjo 
software (Treestar, Ashland, OR, USA) (see Appendix A for additional reagents for all 
experiments). 
2.9  Antibody detection by ELISA 
Blood samples were taken from tail-vein bleeds and collected into serum separator tubes 
(BD Bioscience, San Diego, CA). Samples were centrifuged at 8000 rpm for 10 min at 
4
o
C. L. major-specific IgG1, IgG2a and IgG2b were measured by indirect ELISA using 5 
g/ml soluble L. major antigen (SLA) for coating (overnight at 4oC) on Nunc MaxiSorp 
flat-bottom 96 well ELISA plates (Nunc, Reskilde Denmark). SLA was prepared from 
stationary phase metacyclic promastigotes by sonication 3 times for 30 sec at 4°C in the 
presence of protease inhibitors (Sigma-Aldrich). Soluble cell supernatant was collected by 
centrifugation at 8000 rpm for 10 min at 4
o
C and frozen at -80°C until needed. Protein 
concentration was measured using the BCA protein kit (Pierce, Rockford, IL) according to 
manufactures instructions. Following overnight incubation, the plates were blocked with 
2% milk powder for 3hrs at 37
o
C. Plates were then washed 3× and serum was added in 3-
fold serial dilutions followed by overnight incubation at 4
o
C. After washing 3×, alkaline 
phosphatase (AP)-labelled goat-anti-mouse isotype-specific antibodies (Southern 
Biotechnology, Birmingham, USA) were added for 1hr at 37°C. Total IgE was measured 
by sandwich ELISA using clone 84.1C to coat ELISA plates and anti-mouse IgE (Southern 
Biotechnology, USA) for detection (Nieuwenhuizen et al., 2007). 4-Nitrophenylphosphate 
(PNP, Fluka, Switzerland) at 1 mg/ml dissolved in substrate buffer was added to all 
samples and the absorbance measured at 405 nm on a Versamax microplate 
spectrophotometer (Molecular Devices, Germany) (see Appendix A for additional reagents 
for all experiments). 
2.10  Cytokine detection by ELISA 
The concentration of cytokines IFN- , IL-4, IL-13, IL-12p40, IL-12p70 and IL-10 were 
determined by sandwich ELISA. Nunc MaxiSorp flat-bottom 96 well ELISA plates were 
coated with purified anti-IL-4 (clone 11B11, 2 µg/ml), anti-IFN-γ (clone An18KL6, 1 
µg/ml), anti-IL-13 (clone 38213, 1 µg/ml), anti-IL-10 (clone JES052A5, 1 µg/ml) or anti-
IL-12p40/p70 (p40 clone C15.6, p70 clone 9A5, 1 µg/ml) (all BD Pharminogen) 
antibodies, diluted in carbonate coating buffer, pH 9.5 and incubated overnight at 4
o
C. 
Plates were then blocked with 2% milk powder for 3hrs at 37
o
C, washed 3× with ELISA 











10 or IL-12p40/p70 (BD Pharmingen) or cell supernatants were added in 3-fold serial 
dilutions and incubated overnight at 4
o
C. Following washing 3×, biotinylated anti-mouse 
secondary antibodies for IL-4 (clone: BVD6-24G2), IFN-γ (clone: XMG1.2), IL-13 (goat 
anti-mouse, 0.5 µg/ml), IL-10 (goat anti-mouse, 0.5 µg/ml ) or IL-12p40/p70 (clone C17.8) 
(all BD Pharmingen) were added for 3hrs at 37°C. Plates were then washed 4× and 
incubated with Horseradish peroxidase (HRP)-labeled streptavidin for 1hr at 37
o
C 
followed by incubation with TMB Peroxidase Substrate (KPL, USA) for detection of 
antigen-antibody complexes. The reaction was stopped with 1 M H2SO4 and absorption 
measured at 450 nm (see Appendix A for additional reagents for all experiments). 
2.11  Nitric oxide synthase and arginase measurements 
Lymph node and footpad cells collected at week 4 after L. major IL81 infection were 
restimulated with LPS (Sigma-Aldrich; 10 ng/ml) for 48 hrs at 37
o
C in 5% CO2. Following 
incubation, supernatants were collected for quantification of iNOS activity as previously 
described (Modolell et al., 1995). Briefly, a nitric oxide standard (Na2NO3, 2mM) was 
serially diluted in DMEM in a 96-well plate and supernatants were diluted 1/3 in triplicate. 
25μl of Griess reagent A = Sulfanilamide (1% sulfanilamide in 3% phosphoric acid) was 
then added to the plate followed by an equal volume of Griess reagent B = NED solution 
(N-1-napthyl ethylenediamine dihydrochloride). The plate was then gently rocked to mix 
the solutions and incubated for 5‐10 minutes until a pink dye developed across standard 
wells. Absorption was then mea ured at 540 nm. Arginase activity was measured in cell 
lysates as previously described (Corraliza et al., 1994; Modolell et al., 1995). Briefly, cells 
were lysed with 50 l of 0.1% Triton X-100 (Sigma-Aldrich). After lysis, 50 l of 10 mM 
MnCl2 (Merck) and 50 mM Tris-HCl (Merck) were added, and the enzyme was activated 
by heating for 10 min at 55°C. Arginine hydrolysis was performed by incubating 25 l of 
the activated lysate with 25 l of 0.5 M L-arginine (Merck; pH 9.7) at 37°C for 60 min. 
The reaction was stopped with 400 l of H2SO4 (96%)/H3PO4 (85%)/H2O (1/3/7, v/v/v). 
As a measure of arginase activity, the urea concentration was quantified at 540 nm after 
addition of 25 l of -iso-nitrosopropiophenone (Sigma-Aldrich; dissolved in 100% 
ethanol) followed by heating at 95°C for 45 min. One unit of arginase activity was defined 
as the amount of enzyme that catalyzed the formation of 1 mol urea/min. Expression of 
























iNOS (Abcam) with goat anti-rabbit PE (Abcam) and goat anti-mouse arginase (Santa 
Cruz Biotechnology) with donkey anti-goat PE (Abcam). Purified goat IgG and rabbit IgG 
were used as controls. 
2.12  Histological analysis 
Footpads, spleens and livers were removed from infected mice, fixed in ice-cold 4% 
formaldehyde in phosphate buffered saline and embedded in wax. Wax-embedded tissues 
were cut into 2 µm sections and stained with either haematoxylin and eosin (H&E) or 
Giemsa for detection of inflammatory cells and L. major amastigote parasites. The 
processing and staining of histology sections was performed by Lizette Fick at the 
Department of Surgery, Groote Schuur Hospital. 
2.13  Immunohistochemistry 
OCT (Tissue-Tek; Sakura, Zoeterwoude, Netherlands)-embedded spleen and brain tissue 
from mice infected with GFP-expressing L. major IL81 parasites for 4 weeks was cut into 
10 μm frozen sections and mounted on 3-aminopropyltriethoxysilane (AEPES)-coated 
slides. Following acetone fixation of spleen sections, nuclei were stained with Hoechst 
whilst dendritic cells and macrophages were stained using biotinylated anti-CD11c mAb 
(BD Biosciences) and biotinylated anti-CD68 (RayBiotech), respectively, followed by a 
streptavidin-Cy3 conjugate (Sigma-Aldrich). Cryosections of mouse brain tissue were 
acetone-fixed and then stained with nuclear stain Hoechst. Coverslips were then mounted 
on sections using Mowiol 4-88 mounting medium (Calbiochem) with anti-fade (Sigma-
Aldrich). Images were acquired and analyzed by Ziess LSM 510 confocal microscope 
(Jena, Germany).  













) were first isolated as described above. Cells were seeded into chamber slides and 
localization of GFP
+
 parasites were viewed and analysed by LSM 510 confocal 
microscopy. 
2.14  Quantitative RT-PCR 
CD11c
+
 cells from total lymph node cell suspensions (described above) were positively 
selected using anti-CD11c microbeads (MACS, Miltenyi Biotec), according to the 
manufacturer’s instructions (described above). Eluted CD11c
+















 dendritic cells on a FACS vantage flow cytometer (BD Biosciences, 
Ferndale, South Africa) to a purity of > 99% as determined by FACS. Total RNA was 
extracted from sorted dendritic cells using Tri reagent (Applied Biosystems, Carlsbad, 
Calif) and mini-elute columns (Quiagen, http://www.quiagen.com) according to the 
manufacturer’s protocol. cDNA was synthesized with Transcriptor First Strand cDNA 
synthesis kit (Roche), and real-time PCR of dendritic cell-specific genes (Table 2.2) was 
performed by using Lightcycler FastStart DNA Master PLUS SYBR Green I reaction mix 
(Roche) on a Lightcycler 480 II (Roche). Values were normalized according to the 
expression of the housekeeping genes HPRT or rS12. 
 
Table 2.2: Primers for quantitative RT-PCR of dendritic cell-specific genes 
Gene Target Primer 
IL-12p40 Forward 5' CTGGCCAGTACACCTGCCAC 3' 
IL-12p40 Reverse 5' GTGCTTCCAACGCCAGTTC 3' 
IL-18 Forward 5' TGGTTCCATGCTTTCTGG 3' 
IL-18 Reverse 5' TCCGTATTACTGCGGTTGT 3' 
IL-10 – Forward  5' AGCCGGGAAGACAATAACTG 3' 
IL-10 – Reverse  5' CATTTCCGATAAGGCTTGG 3' 
IL-23p19 – Forward  5' CAGCTTAAGGATGCCCAGGTT 3' 
IL-23p19 – Reverse  5' TCTCACAGTTTCTCGATGCCA 3' 
A subunit (Activin A) – Forward 5' GAGAGGAGTGAACTGTTGCT 3' 
A subunit (Activin A) – Reverse 5' TACAGCATGGACATGGGTCT 3' 
HPRT – Forward 5' GGCCATGAGGCTGGATCTC 3' 
HPRT Reverse 5' AACATTTGAATCCTGCAGCCA 3' 
 
2.15  Statistics 
Data is represented as mean ± SD. Statistical analysis was performed using the unpaired 
Student’s t test or 1-way Anova with Bonferroni’s post test, defining differences to IL-
4R
-/lox
 mice as significant (*, p  0.05; **, p  0.01; ***, p  0.001) unless otherwise 























































Mice expressing Cre recombinase (Cre)  under control of the CD11c locus (Caton et al., 
2007) were backcrossed to BALB/c for 9 generations, then intercrossed with global IL-
4R
-/- 
BALB/c mice (Mohrs et al., 1999) to generate CD11ccreIL-4R -/- mice on a pure 
BALB/c genetic background. These mice were subsequently intercrossed with floxed IL-
4R
lox/lox












described in Hurdayal and Nieuwenhuizen et al., (Submitted manuscript). Analysis of IL-
4R  surface expression on different cell types by flow cytometry demonstrated that IL-
4R  was efficiently depleted in DCs of the lymph nodes, spleen, skin and lungs, when 
compared with IL-4R
-/lox 
littermate controls and IL-4R
-/-




















 BALB/c mice 
IL-4R  surface expression was analyzed by flow cytometry from naïve IL-4R -/lox (solid line), IL-
4R -/- (dashed line) and CD11ccreIL-4R -/lox (grey tinted) mice. Dendritic cells (DCs) were 
CD11c+MHCII+ (SiglecF- in lungs), alveolar macrophages (Mph) were CD11c+SiglecF+, peritoneal 
macrophages were F480+CD11b+, B cells were CD19+CD3- and T cells were CD3+CD19-. GM = 













 alveolar macrophages also had abrogated IL-4R  surface expression. 
Other cell types such as T cells, B cells and macrophages had comparable IL-4R  
expression to IL-4R
-/lox
 littermate controls.  










mice, we generated bone 
marrow-derived dendritic cells (BMDCs) and stimulated them with LPS in the presence or 
absence of recombinant IL-4 or IL-13. Total yield of BMDCs from precursor cells seeded 




mice and littermate controls and viability after 
maturation was also comparable. IL-4 has been shown to promote Th1 immune responses 
by enhancing DC production of IL-12 in an IL-4R  dependent manner, better known as  
“IL-4-mediated DC instruction theory” (Biedermann et al., 2001; Lutz et al., 2002). As 
previously reported, BMDCs derived from mice with a functional IL-4R , the IL-4R
-/lox 
mice and BALB/c wildtype controls, had significantly increased IL-12p40 production after 





mice or from global IL-4R
-/-
 mice, with a functional deletion of the IL-4R  
chain, showed similar levels of IL-12 to those stimulated with LPS alone, with the addition 
of IL-4 having no effect (Figure 3.2A). These results demonstrate functional impairment of 




mice. Interestingly, after the addition 
of LPS alone, BMDCs with a functional IL-4R  already showed a trend towards increased 
IL-12p40 levels, suggesting that endogenous levels of IL-4 released from small numbers of 
contaminating granulocytes in culture could influence these BMDCs. In contrast, 
stimulation of BMDCs with exogenous IL-13 did not increase levels of IL-12p40 (Figure 
3.2A), which has been reported in previous DC stimulation studies (Lutz et al., 2002). 
Furthermore, addition of recombinant IL-4 and IL-13 to BMDC cultures had no significant 




mice, as shown by similar 
expression levels of DC activation markers such as MHCII, CD80 and CD86 (Figure 
3.2B). These results are consistent with a very recent publication (Cook et al., 2012), 



















































BALB/c mice.  
Bone marrow derived DCs (BMDCs) were generated from bone marrow progenitors in 
CD11ccreIL-4R -/lox and control mice.  
(A) BMDCs were stimulated with LPS in the presence or absence of IL-4 or IL-13 and IL-12p40 
was measured in the supernatants 48 hours later. *, p <0.05, **, p ≤  0.01.  
(B) BMDCs were stimulated with LPS (black line) in the presence or absence of IL-4 (red line) or 
IL-13 (blue line) plus medium control (grey tinted) and expression of DC activation markers was 
analysed by flow cytometry.  
A representative of one of two individual experiments is shown with values ± SEM. Statistical 
analysis was performed defining differences to LPS treatment as significant (*, p ≤  0.05; **, p ≤ 
0.01). 
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 BALB/c mice are hypersusceptible to acute Leishmania major 
infection 
3.3.1  Acute infection with L. major LV39 and L. major IL81 





BALB/c mice were infected subcutaneously with 2 × 
10
6
 stationary phase metacyclic promastigotes of L. major LV39 (MRHO/SV/59/P; Figure 
3.3, A-C) with a more virulent L. major IL81 (MHOM/IL/81/FEBNI; Figure 3.4, A-C) or 
with GFP-expressing IL81 (MHOM/IL/81/FEBNI; Figure 3.4, D-F) strains into the hind 
footpad. 
GFP-expressing IL81 parasites were used in order to facilitate in vivo tracking of 
Leishmania parasites in some experiments. Infection studies with L. major IL81 and GFP-
expressing IL81 parasites were compared to first ascertain whether insertion of the GFP 
cassette in the L. major genome hampered its ability to infect experimental animals. As 
depicted in Figure 3.4, A-C and D-F, infection kinetics between L. major IL81 and GFP-
expressing IL81 Leishmania parasites were similar, confirming that the GFP insert did not 
have an inhibitory effect on Leishmania infection.  
As previously shown (Mohrs et al., 1999; Radwanska et al., 2007), C57BL/6 mice and IL-
4R
-/-
 deficient BALB/c mice controlled lesion development during acute infection with 
all indicated L. major strains (Figure 3.3A, Figure 3.4A and 3.4D), which correlated with 
low parasite numbers in infected footpads (Figure 3.3B, Figure 3.4B and 3.4E) and 
draining lymph nodes (LN) (Figure 3.3C, Figure 3.4C and 3.4F). Susceptible WT BALB/c 
and IL-4R
-/lox
 littermate control mice developed progressive footpad swelling after 
infection with all indicated strains (Figure 3.3A, Figure 3.4A and 3.4D), with increased 
parasite burdens in the infected footpads (Figure 3.3B, Figure 3.4B and 3.4E) and draining 
LN (Figure 3.3C, Figure 3.4C and 3.4F). Hemizygous (IL-4R
-/lox 
mice) had slightly 
reduced footpad swelling compared to BALB/c mice in IL81 infection. The greater 
virulence of the L. major IL81 strain is reflected in more rapid disease progression, with 
footpad swelling and parasite burden reaching similar levels by 4 weeks (Figure 3.4) to 

























Figure 3.3: CD11ccreIL-4R -/lox BALB/c mice are hypersusceptible to acute L. major LV39 
infection.  
Mice were infected with L. major LV39 (MRHO/SV/59/P) strain.  
(A-C) Footpad swelling was measured at weekly intervals (5 mice per group) infected 
subcutaneously with 2×106 stationary phase metacyclic L. major promastigotes into the hind 
footpad. Parasite burden was determined by limiting dilution of homogenized footpads (B) and 
single-cell suspensions of lymph nodes (C) at 8 weeks after infection. 
 “N” indicates necrosis or ulceration/mouse. A representative of one of two individual experiments 
is shown with values ± SEM. Statistical analysis was performed defining differences to IL-4R -/lox 






 mice were hypersusceptible to acute L. major infection 
compared to heterozygous littermate controls and BALB/c mice, showing significantly 
worsened disease progression when infected with all three strains (Figure 3.3 and Figure 
3.4), with earlier and dramatically larger footpad lesions, and development of early 
necrosis (Figure 3.3A, Figure 3.4A and 3.4D). Increased disease progression was 
accompanied by significantly higher parasite numbers in the footpads (Figure 3.3B, Figure 



















































Figure 3.4: CD11ccreIL-4R -/lox BALB/c mice are hypersusceptible to acute L. major IL81 
infection.  
(A-C) Mice were infected with the virulent L. major IL81 (MHOM/IL/81/FEBNI) strain. Footpad 
swelling was measured at weekly intervals in mice (4 per group) infected subcutaneously with 
2×106 stationary phase metacyclic L. major promastigotes into the hind footpad (A). Parasite 
burden was measured by limiting dilution of homogenized footpads (B) and single-cell suspensions 
of lymph nodes (C) at 4 weeks after infection. 
(D-F) Mice were infected with a GFP-expressing L. major IL81 (MHOM/IL/81/FEBNI) strain. 
Footpad swelling was measured at weekly intervals (5 mice per group) infected subcutaneously 
with 2×106 stationary phase metacyclic L. major promastigotes into the hind footpad (D). Parasite 
burden was measured by limiting dilution of homogenized footpads (E) and single-cell suspensions 
of lymph nodes (F) at 4 weeks after infection  
“N” indicates necrosis or ulceration/mouse A representative of one of two individual experiments 
is shown with values ± SEM. Statistical analysis was performed defining differences to IL-4R -/lox 
mice as significant (*, p ≤ 0.05, **, p ≤  0.01, ***, p ≤ 0.001). 
 









 footpads at week 4 after 
infection with the virulent IL81 showed severe, non-healing inflammatory lesions (Figure 




 mice revealed severe 
destruction of epidermis, connective tissue and bone as a result of footpad necrosis, 
accompanied by increased inflammatory cells and a high load of extracellular L. major 
amastigotes (Figure 3.5B). In contrast, infected footpads of IL-4R
-/lox











dermal inflammatory infiltrates with mostly intact epidermis, connective tissue and bone 
(Figure 3.5B).  Together, these data reveal that IL-4R  signaling on DCs play an important 

























infected mice.  
Mice were infected with the virulent L. major IL81 (MHOM/IL/81/FEBNI) strain. Infected 
footpads were collected at week 4 after infection. 
(A) Representative images of L. major IL81-infected footpads at week 4. 
(B) Formalin-fixed footpads were stained with Giemsa for histopathology (original magnification 
×40; asterisks indicate inflammatory foci and insets, arrows indicate amastigote parasites ×800). 
Representative images of one of two individual experiments is shown.  
 




 BALB/c mice 
during L. major infection 





during acute Leishmaniasis (IL81) was accompanied by an altered immune response, we 
examined cellular and humoral Th1/Th2-type immune responses during acute 
Leishmaniasis. Antigen-specific restimulation of CD4
+
 T cells sorted from the LN of 
infected mice and co-cultured with fixed antigen-presenting cells and soluble Leishmania 





in comparison to the resistant C57BL/6 or IL-4R
-/-
 strains as well as to the susceptible IL-
4R
-/lox











































Figure 3.6: T helper 2 immunity is enhanced in hypersusceptible CD11ccreIL-4R -/lox mice 
during acute L. major IL81 infection. 
Experimental mice were infected subcutaneously with 2×106 stationary phase metacyclic GFP-
expressing L. major IL81 promastigotes into the hind footpad. 
(A-D) At week 4 post infection, total CD4+ T cells from the draining lymph node were restimulated 
for 72 hrs with APCs and soluble Leishmania antigen (SLA). The production of IFN-  (A), IL-4 
(B), IL-13 (C) and IL-10 (D) was determined by ELISA.  
(E-G) Also at week 4 post infection, antigen-specific IgG2a (E), IgG1 (F) and total IgE (G) 
antibody production was quantified from infected sera by ELISA. 
A representative of one of two individual experiments is shown with values ± SEM. Statistical 
analysis was performed defining differences to IL-4R -/lox mice as significant (*, p ≤ 0.05, **, p ≤ 
0.01 ***, p ≤ 0.001). 
 
Similar results were also obtained with T cell mitogenic (anti-CD3) and antigen-specific 
restimulation of total lymph node cells at week 4 after infection (data not shown). The 
observed shift towards Th2-type responses was further confirmed systemically in the 
quality of Leishmania-specific antibody immune responses. Sera of week 4 infected mice 
revealed a predominant type 1 antibody response in IL-4R
-/-
 mice, as shown by elevated 
levels of Leishmania-specific IgG2a (Figure 3.6E). In contrast, CD11ccreIL-4R -/lox mice 











IgG1 and total IgE which was significantly higher than that observed in littermate IL-4R
-
/lox
 mice (Figure 3.6F and 3.6G). Similar results were obtained from infections with L. 
major LV39 (data not shown). Together, these data indicate that CD11ccreIL-4R -lox mice 
have a shift towards a dominant CD4
+
 Th2-type immune response, which is likely to 
contribute to the hypersusceptible disease phenotype. 










 BALB/c mice are hypersusceptible to 10-fold lower dose of L. 
major LV39 parasites 
We next sought to examine the influence of parasite dose on disease progression and 
Th1/Th2 cell differentiation in vivo in CD11ccreIL-4R -/lox mice and control groups (Figure 
3.7 and 3.8). Infection using a 10-fold lower dose (2×10
5
) of L. major LV39 parasites also 




 mice (Figure 3.7A) 
accompanied by significantly higher parasite numbers in the footpads (Figure 3.7B) and 
LN (Figure 3.7C) of infected animals. IL-4R
-/-
 and C57BL/6 mice developed a healing 
response to 2×10
5 L. major infection, characterized by lower numbers of parasites in the 
















Figure 3.7: CD11ccreIL-4R -/lox mice are hypersusceptible to 10-fold lower dose cutaneous L. 
major infection.  
Experimental mice were infected subcutaneously with 2×105 stationary phase metacyclic L. major 
LV39 promastigotes into the hind footpad.  
(A-C) Footpad swelling was measured at weekly intervals in mice (5 per group) infected 
subcutaneously with 2 × 105 metacyclic L. major promastigotes into the hind footpad (A). “N” 
indicates necrosis or ulceration/mouse. Parasite burden was determined by limiting dilution of 
single-cell suspensions from homogenized footpads (B) and lymph nodes (C) at week 8.  
A representative of one of two individual experiments is shown with values ± SEM. Statistical 















 BALB/c mice during 
2×10
5
 L. major LV39 infection 
Infection with a 10-fold lower dose of L. major LV39 did not promote a switch to a 




 or in BALB/c control mice (Figure 





 mice also had a predominant type 2 antibody response characterized 
by reduced IgG2a (Figure 3.8C) and marked production of IgG1 and total IgE (Figure 3.8D 
and 3.8E), which was significantly higher than that observed in littermate IL-4R
-/lox
 mice. 
C57BL/6 maintained a strong IFN-  healing response to 2×10
5 L. major parasites up to 8 
weeks (Figure 3.8). Taken together, infection with a 10-fold lower dose of L. major 



















Figure 3.8: T helper 2 immunity is enhanced in hypersusceptible CD11ccreIL-4R -/lox mice 
during 10-fold lower dose infection with L. major LV39.  
Mice were infected subcutaneously with 2×105 L. major LV39 promastigotes into the hind footpad. 
(A-B) At week 8 after infection, total cells from the draining lymph node were restimulated for 72 
hrs with medium, CD3 and soluble Leishmania antigen (SLA). The production of IFN-  (A) and 
IL-4 (B) was determined by ELISA.  
(C-F) At week 8 after infection, antigen-specific IgG2a (C), IgG1 (D) and total IgE (E) antibody 
production was quantified from infected sera by ELISA.  
A representative of one of two individual experiments is shown with mean values ±SEM. 
Statistical analysis was performed defining differences to IL-4R -/lox mice as significant (*, p ≤ 











3.6  Absence of IL-4R  signaling on dendritic cells leads to alternative activation of 
macrophages during L. major infection 
As IFN- -induced nitric oxide synthase (iNOS) production by classically activated 
macrophages is a key control mechanism in L. major infection (Stenger et al., 1994), the 
activation state of macrophages was determined in the infected footpad at week 4 after 













 mice had significantly reduced iNOS expression compared to those of littermate 
IL-4R
-/lox





























 mice have reduced iNOS and 
increased Arg I during L. major IL81 infection. 
Experimental mice were infected with L. major IL81 and at week 4 after infection, the activation 
phenotypes of inflammatory macrophages at the site of infection were analysed.  
(A-B) Total cells were isolated from infected footpads and surface-stained for FSChi 
CD11b+MHCII+CD11c- macrophages followed by intracellular staining for iNOS (A) and arginase 
1 (B). GM = Geometric Mean.  
(C-D) Total cells were isolated from infected footpads and stimulated with 10 ng/ml LPS for 72 h. 
Production of NO was determined in cell supernatants (C) and cell lysates were assayed for 
arginase I production (D). A representative of two individual experiments is shown with mean 
values ± SEM. Statistical analysis was performed defining differences to IL-4R -/lox mice as 



























Conversely, expression of arginase I, a marker of alternatively activated macrophages, was 




 mice (Figure 3.9B). This altered phenotype 
in macrophage activation was confirmed in iNOS and arginase activity assays performed 





BALB/c mice produced significantly reduced amounts of NO and significantly increased 
arginase activity in response to LPS stimulation, in comparison to control mice (Figure 





 mice, which could account for the uncontrolled parasite 













 mice  
At week 8 after infection with L. major LV39 and GFP-IL81 strains, CD11ccreIL-4R -/lox 
mice displayed noticeable splenomegaly (Figure 3.10), which prompted us to evaluate 
parasite dissemination in peripheral organs using two-fold limiting dilution assays. As 
studies in BALB/c mice have suggested that the presence of parasites in peripheral organs 
could occur as a result of parasites disseminating to these sites within 24 hours from the 
onset of infection, but beginning to replicate at a later time-point (Laskay et al., 1995; 
Schilling and Glaichenhaus, 2001), we decided to evaluate parasite dissemination to 
















 mice during L. major infection 
(A-B) Mice were infected subcutaneously with 2 × 106 stationary phase metacyclic L. major LV39 
(A) and GFP-expressing L. major IL81 (MRHO/SV/59/P) strain (B) into the hind footpad and 
spleens were weighed at week 8 and week 4 after infection, respectively.  
A representative of one of two individual experiments is shown with mean values ±SEM. 
Statistical analysis was performed defining differences to IL-4R -/lox mice as significant (*, p ≤ 













 L. major IL81 infected mice, an increase in GFP+ parasites was not detectable in 
the spleen at 1 or 3 days post infection using flow cytometry, whereas at week 4, GFP
+
 





mice occurred at a later time-point. Moreover, both at 
early time-points and at week 4, DCs contained significantly higher GFP
+
 loads than 



































Mice were infected subcutaneously with 2 × 106 stationary phase metacyclic GFP-expressing L. 
major IL81 (MRHO/SV/59/P) strain into the hind footpad. At Day 0 (D0), Day 1 (D1), Day 3 (D3) 
and Week 4 (WK4) after infection, total spleen cells were surface stained for DCs 
(CD11c+MHCII+), Mph (CD11b+MHCII+CD11c-) and neutrophils (GR1hiCD11c-). The percentage 
of infiltrating GFP+-infected cells were determined by flow cytometry. 
A representative of one of two individual experiments is shown.  
 




 mice during L. major infection 




and littermate control mice 
during the acute phase of L. major infection. In L. major LV39 infected CD11ccreIL-4R -
/lox 
mice, parasites were only found in footpads and the draining lymph nodes at week 3, 





mice and littermate controls (Figure 3.12A and 3.12B). Parasite burdens were much 
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mice, compared to littermate control 
mice. Moreover, depending on the degree of hypersusceptibility, it was surprising to find 





mice, but not in control mice (Figure 3.12C).  





 mice already displayed noticeable splenomegaly at 4 
weeks post infection (Figure 3.10B) and had strikingly increased parasite burdens in all 


















Figure 3.12: Impaired IL-4-mediated dendritic cell instruction results in increased L. major 
parasite loads. 
CD11ccreIL-4R -/lox and littermate mice were infected subcutaneously with 2×106 stationary phase 
metacyclic L. major (L. m LV39 or GFP-L. m IL81 promastigotes into the hind footpad.  
(A-B) Parasite load was determined by limiting dilution assay (LDA) of homogenized footpads and 
single-cell suspensions from lymph nodes, spleens, livers and brains at week 3 (A) and week 8 (B) 
after infection with L. major (L. m LV39).  
(C) Similarly, parasite load was determined by limiting dilution assay of homogenized footpads 
and single-cell suspensions from lymph nodes, spleens, livers and brains at week 4 after infection 
with GFP-expressing L. major (L. m IL81). 
A representative of one of two individual experiments is shown with mean values ± SEM. 
Statistical analysis was performed defining differences to IL-4R -/lox mice (*, p ≤ 0.05, **, p ≤  

















 mice during L. 
major infection 
Histological analysis confirmed the increased presence of disseminated parasites in the 




 mice (IL81, week 4), as shown by the high load of 
extracellular L. major amastigotes (spleen) and the prevalence of inflammatory foci and 




































CD11ccreIL-4R -/lox and littermate control mice were infected subcutaneously with 2×106 stationary 
phase metacyclic GFP-L. major IL81 parasites in the hind footpad.  
(A) At week 4 after infection, formalin-fixed spleen and liver were stained with H&E and Giemsa 
respectively, for histopathology (original magnification ×100; asterisks indicate inflammatory foci 
and insets, arrows indicate amastigote parasites ×800).  
(B) Cryosections of brain tissue were stained with Hoechst nuclear stain (Blue) and visualized by 
confocal microscopy for GFP+-L. major amastigote parasites (original magnification ×400). A 
















 mice was a consequence of parasites present in the blood 
brain barrier or the meninges, the localization of GFP
+





mice at week 4 after infection was examined by confocal 
microscopy. GFP
+
 L. major parasites were found within cells in cryosections of brain 




 mice, but not in control mice (Figure 3.13B), 
indicating that L. major parasites traversed the immunological blood-brain barrier to reside 
in the brains of these mice. Together, these results demonstrate that the absence of IL-4R  
signaling on DCs in L. major infected CD11ccreIL-4R -/lox mice results in a substantial 
increase in parasite numbers in peripheral organs. Moreover, based on the combined results 
of these experiments, the presence of L. major parasites at peripheral sites seems likely to 
be a consequence of disease-related parasite dissemination and not a result of late parasite 
replication subsequent to injection, since parasites were not detected in these sites at earlier 
time points.  
 
3.8  IL-4R -deficient CD11b
+
 DCs are the major infected cell type in footpad, lymph 
node and spleen  
3.8.1  Viability and localization of GFP
+





 mice showed enhanced dissemination of L. major parasites in 
peripheral organs, we sought to investigate if specific cell populations were important in 




 and littermate control mice 
were infected with GFP-expressing L. major IL81 parasites and GFP positivity was used to 
track infected cell populations in different organs by flow cytometry. To first confirm that 
GFP
+
 cell populations were indeed associated with live L. major parasites and not 
harboring fragments of GFP
+
 amastigotes, a variety of cell populations, namely; dendritic 
cells, macrophages, neutrophils and B cells, were FACS sorted and plated out for limiting 
dilution assays. Parasite replication occurred in all GFP
+
 cell populations indicating that 
GFP positivity was a good marker for viable parasites associated with cells (Figure 3.14A). 
In contrast, GFP
+




 T cells (data not 
shown). To further confirm that cells contained intracellular GFP
+
 parasites, confocal 
microscopy was performed on sorted cells at 4 week after infection. Confocal imaging 
revealed that GFP
+ 
parasites associated with phagocytes, such as macrophages, were 
intracellular, whereas GFP
+ 
parasites associated with lymphocytes, such as B cells, were 










































Figure 3.14: GFP+-L. major parasites in immune cell populations in CD11ccreIL-4R -/lox mice. 
Experimental mice were infected subcutaneously with GFP-expressing L. major IL81 
promastigotes into the hind footpad.  
(A) At week 4 after infection, single-cell suspensions of lymph node cells were surface stained for 
dendritic cells (DCs-CD11c+CD11b+MHCII+), macrophages (Mph-CD11b+MHCII+CD11c-), 
Neutrophils (Neut-GR1+CD11c-) and B cells (CD19+, CD11c-) and FACS sorted for these immune 
cell populations. Sorted cells were plated out in two-fold dilutions to determine viable parasite 
burden by limiting dilution assay.  
(B) At week 4 after infection, footpad macrophages (CD11b+MHCII+CD11c-) and lymph node B 
cells (CD19+CD3-CD11c-) were isolated on a cell sorter, seeded into chamber slides and the 
localization of GFP+ parasites were viewed and analysed by LSM 510 confocal microscopy. A 
representative of one of two individual experiments is shown with mean ± SEM. 
 




 mice during L. major infection 
Cutaneous Leishmaniasis is characterized by a localized inflammatory response at the site 
of infection and the immediate draining lymph node (dos Santos et al., 2008). We therefore 
evaluated cellular infiltration as an indication of inflammation in the footpad and draining 
popliteal lymph node at day 3 and week 4 after infection with GFP
+
 L. major IL81 

















developed an earlier, stronger inflammatory response in the lymph nodes at the initial 
stages of infection (day 3), with recruitment of a significantly higher number of total cells 
into the lymph node (Figure 3.15A). By week 4 the total number of lymph node cells was 
comparable between the two groups (Figure 3.15B). During early infection (day 3), there 




 and control 




 mice had 
exacerbated inflammation as shown by the significantly higher cell numbers when 
compared to control mice (Figure 3.15B). This suggests that the continuous recruitment of 





 mice, the effects of which are seen in the increased 


















CD11ccreIL-4R -/lox and littermate mice were infected subcutaneously with 2×106 stationary phase 
metacyclic GFP-expressing L. major IL81 promastigotes into the hind footpad. 
(A-B) Footpads and lymph nodes were analysed for cell infiltration at day 3 (A) and week 4 (B) 
after infection in CD11ccreIL-4R -/lox and littermate mice. A representative of one of two individual 
experiments is shown with mean ± SEM. Statistical analysis was performed defining differences to 
IL-4R -/lox mice (**, p ≤  0.01). 
 
3.8.3  Cellular populations infected with GFP
+
-L. major parasites in CD11ccreIL-4R -/lox 
BALB/c mice  
Total footpad and lymph node cells were analyzed for specific cell populations harboring 
GFP
+
 L. major parasites at both early (day 3) and late time points (week 4) following 
infection. At day 3 after infection, a large proportion of phagocytic cells, particularly, 
plasmacytoid DCs (pDCs), macrophages and neutrophils, had infiltrated the infected 
footpad (Figure 3.16A). By week 4 after infection, numbers of infiltrating cells had 
















 mice compared to IL-4R
-/lox
 mice (Figure 3.16B). At the early time point (day 3), 
macrophages were the dominant cell type infected with GFP
+
 Leishmania in the footpad, 




mice and littermate controls (Figure 3.16C). 
This was in contrast to the draining lymph node, where conventional and plasmacytoid 
DCs were predominantly infected (Figure 3.16D), suggesting that these cells were more 
important in delivering the parasites to the lymph node. Significantly increased numbers of 




mice compared to controls (Figure 
3.16D). At week 4 after infection, the footpad harbored particularly high numbers of GFP
+
 
L. major infected macrophages, cDCs and neutrophils (Figure 3.16E), while in the draining 
lymph node, the cDCs were still the dominant infected cell type (Figure 3.16F). Again the 




 mice (Figure 
3.16E and 3.16F) compared to littermate controls.  
Conventional DCs form a highly heterogeneous cell population consisting of various 
subsets (e.g. myeloid, lymphoid, follicular and plasmacytoid) (Scott and Hunter, 2002),  
therefore we performed further FACS staining at early and late time-points after infection 
to determine if any particular DC subset was important in harboring and disseminating L. 
major in infected mice.  At day 3 (Figure 3.17A), CD11b+ DCs were the main subset 
infected with L. major in the footpads but in the LN there was a large population of 
CD103
+
 DCs (tissue DCs) that harbored L. major parasites (Figure 3.17B). We also 
observed similar populations of infected cells at day 7 after infection. Later, at week 4, 
CD11b
+
 DCs were the main infected DC population in both the footpad and lymph node 
(Figure 3.17C and 3.17D). CD11b
+
 DCs were the main cell type containing L major 































































CD11ccreIL-4R -/lox and littermate mice were infected subcutaneously with 2×106 stationary phase 
metacyclic GFP-expressing L. major IL81 promastigotes into the hind footpad.  
(A-B) Footpad cells were analysed for total immune cell populations at day 3 (A) and week 4 (B) 
after infection by FACS staining.  
(C-D) At day 3 after infection, the number of cells containing GFP+ L. major parasites was 
identified within the indicated cell populations derived from footpad (C) and lymph node (D).  
(E-F) At week 4 after infection, the number of cells containing GFP+ L. major parasites was 
identified within the indicated cell populations derived from footpad (E) and lymph node (F).  
Cell populations were differentiated based on the following markers; conventional dendritic cells 
(cDCs; CD11c+MHCII+), plasmacytoid DCs (pDCs; CD11c+PDCA+SiglecH+), macrophages (Mph; 
CD11b+MHCII+CD11c-), Eosinophils (Eos; SiglecF+CD11c-/int), Neutrophils (Neut; GR-
1highSSChighFSChigh CD11c-). A representative of one of two individual experiments is shown with 
mean ± SEM. Statistical analysis was performed defining differences to IL-4R -/lox mice (*, p ≤ 









































 inflammatory dendritic cells disseminate L. major parasites from the site 
of infection.  
CD11ccreIL-4R -/lox and littermate mice were infected subcutaneously with 2×106 stationary phase 
metacyclic GFP-expressing L. major IL81 promastigotes into the hind footpad.  
(A-B) The number of cells containing GFP+ L. major parasites were identified within cDC subsets 
derived from footpad (A) and lymph node (B) at day 3 after infection.  
(C-D) The number of cells containing GFP+ L. major parasites were identified within cDC subsets 
derived from footpad (C) and lymph node (D) at week 4 after infection.  
(E-F) Spleens were harvested to analyse GFP+ L. major parasites in the indicated cell populations 
(E) and DC subsets (F) at week 4 after infection.  
Cell populations were differentiated based on the following markers; conventional dendritic cells 
(cDCs; CD11c+MHCII+), plasmacytoid DCs (pDCs; CD11c+PDCA+SiglecH+), CD103+ DCs 
(CD11c+CD103+), CD4+ DCs (CD11c+CD4+CD3-), CD8+ DCs (CD11c+CD8+CD3-), CD11b+ DCs 
(CD11c+CD11b+MHCII+), macrophages (Mph; CD11b+MHCII+CD11c-), Eosinophils (Eos; 
SiglecF+CD11c-), Neutrophils (Neut; GR-1highCD11c-). A representative of one of two individual 
experiments is shown with mean ± SEM. Statistical analysis was performed defining differences to 











3.8.4  Infiltration of CD11b
+




 mice during 
L. major infection  
Seeing that CD11b
+
 DCs were the preferred host cells for L. major parasites, we next 
examined the numbers of CD11b
+
 DCs infiltrating the spleen during infection with GFP-
expressing L. major IL81 parasites. We found that overall numbers of CD11b+ DCs were 




mice and littermate 
controls at day 1 and day 3 as well as by week 4 after infection (Figure 3.18). This 
suggested that differences in parasite killing in infected DCs and not migration of infected 
DCs might be responsible for the increased numbers of GFP
+






























Mice were infected subcutaneously with 2×106 stationary phase metacyclic GFP-expressing L. 
major IL81 (MRHO/SV/59/P) strain into the hind footpad. The number of infiltrating CD11b+ DCs 
in spleen of CD11ccreIL-4R -/lox and littermate mice was quantified by flow cytometry at Day 0 
(D0), Day 1 (D1), Day 3 (D3) and Week 4 (WK4) after infection. 
















































3.8.5 Immunohistochemistry confirms the presence of GFP
+
 parasites in dendritic cells 




 mice  
In order to supplement the flow cytometry data and confirm the presence of higher 
numbers of intracellular GFP
+





vivo, we performed confocal microscopy on lymph node and spleen cryosections. 
Fluorescent staining of dendritic cells and macrophages in spleen tissue confirmed that 
dendritic cells were a major reservoir of intracellular GFP
+





mice, with a higher concentration of green fluorescent foci (GFP
+
) 
than macrophages (Figure 3.19A).  
Quantification of intracellular GFP
+
 L. major amastigote parasites in dendritic cells 





mice in both the lymph node (Figure 3.19B) and spleen (Figure 3.19C) compared to 
littermate control mice. Moreover, quantitative analysis further revealed that dendritic cells 




mice had higher GFP
+
 L. major parasite 
loads in comparison to the amount of intracellular GFP
+
 parasites in macrophages. Taken 
together, the finding that CD11b
+
 DCs constitute the major source of infected cells in LN 
and spleen and the well-established migratory properties of DCs suggests that they may 





controls. Moreover, these results suggest that differences in the survival and/or growth of 
parasites within IL-4R  deficient CD11b
+
 DCs, as opposed to migration of these DCs, 
































































Figure 3.19: Dendritic cells predominantly harbor GFP
+
 L. major parasites in lymph nodes 





Mice were infected subcutaneously with 2×106 stationary phase metacyclic GFP-expressing L. 
major IL81 promastigotes into the hind footpad.  
(A) After 4 weeks of infection, crysections of lymph node and spleen were stained with Hoechst 
nuclear stain (Blue) and mAb against CD11c+ dendritic cells or CD68+ macrophages (red). The 
figure shows representative micrographs of spleen cryosections showing distribution and 
localization of GFP+ L. major-infected (green) CD11c+ dendritic cells and CD68+ macrophages 
(red) from CD11ccreIL-4R -/lox and littermate mice (original magnification ×400). Insets show 
individual channels.  
(B-C) The number of GFP+ amastigote parasites in dendritic cells and macrophages from 
CD11ccreIL-4R -/lox and littermate control mice stained with mAb against CD11c+ DCs and CD68+ 
macrophages, were quantified from multiple lymph node (B) and spleen (C) cryosections of 
individual mice by confocal microscopy. Data is expressed as mean ± SEM. Statistical analysis was 
performed defining differences to IL-4R -/lox mice (*, p ≤ 0.05, **, p ≤ 0.01) or to infected 






























3.9  IL-4R -deficient dendritic cells have impaired IL-4-mediated instruction and 










To test the relevance of IL-4-mediated DC instruction in vivo in our model, CD11ccreIL-
4R
-/lox
 mice and controls were infected with L. major IL81 and at 4 weeks post infection 
total LN cells were restimulated with SLA to measure production of IL-12p40 and IL-10 





produced significantly reduced IL-12p40 but increased IL-10 compared to littermate IL-
4R
-/lox





















Figure 3.20: Abrogation of IL-4R  expression on dendritic cells impairs IL-4-mediated 
dendritic cell instruction during L. major infection.  
Mice were infected subcutaneously with 2×106 stationary phase metacyclic GFP-L. major IL81 
promastigotes into the hind footpad for 4 weeks.  
(A) Total lymph node cells were restimulated with SLA and production of IL-12p40 and IL-10 was 
determined by ELISA at week 4 after infection.  
(B) Total lymph node cells were restimulated with PMA/Ionomycin/Monensin and intracellular 
levels of IL-12p40 and IL-10 in dendritic cells was determined by flow cytometry at week 4 after 
infection. 
(C) BMDCs were infected with L. major in the presence or absence of recombinant IL-4 or IL-13. 
Culture supernatants were collected after 48 hours to determine IL-12p70 levels by ELISA. 
A representative of one of two individual experiments is shown with mean values ± SEM. 

















produced less IL-12p40 and more IL-10 than those from littermate IL-4R
-/lox
 controls 
(Figure 3.20A and Figure 3.20B). In addition, differences in IL-12p70 production were 
detected in vitro (Figure 3.20C). L. major/IL-4 stimulated BMDCs derived from IL-4R -
/lox 
mice showed increased IL-12p70 production in agreement with previous reports (Lutz 





mice (Figure 3.20C). IL-13 did not increase IL-12p70 production, as 
previously shown (Lutz et al., 2002) in CD11ccreIL-4R -/lox mice or control animals. 










 DCs from the lymph nodes of L. major-infected CD11ccreIL-4R -/lox and 
littermate control mice were positively selected using MACs beads then gated as shown 
(Figure 3.21A) and FACS sorted to a purity of 99%. We assessed characteristic dendritic 
cell morphology by Diff-Quick staining (Figure 3.21B). mRNA was isolated from sorted 
DCs and converted to cDNA after which RT-PCR was performed. Quantification of 
mRNA demonstrated decreased expression of the genes for IL-12p40 and the Th1-




 mice compared to 
controls (Figure 3.21A and 3.21B). In contrast, there was a trend towards increased mRNA 
expression of IL-10 (Figure 3.21C) as well as significantly increased mRNA expression of 
IL-23 (Figure 3.21D) and activin A (Figure 3.21E), cytokines which are involved in 
promoting Th2 responses by inducing Th17 cells and alternative activation of 
macrophages, respectively (Ogawa et al., 2006; Lopez Kostka et al., 2009). Together, 
these results indicate that IL-4R -mediated DC instruction occurs in vivo, with IL-4R  
deficient DCs producing more IL-10, which could subsequently lead to reduced IL-12 and 
IL-18 responses after exposure to L. major parasites, resulting in an impairment of 































































 mice at week 4 after infection.  
Mice were infected subcutaneously with 2×106 stationary phase metacyclic GFP-L. major IL81 
promastigotes into the hind footpad.  
(A-B) CD11c+MHCII+ DCs from lymph nodes of L. major IL81 infected mice were gated as shown 
and FACS sorted to 99% purity. Cell morphology was assessed by Diff-Quick staining (B).  
(C-G) mRNA was isolated from sorted DCs and converted to cDNA. cDNA was used in SYBR-
Green RT-PCR to measure mRNA expression of IL-12p40 (C) and IL-18 (D), IL-10 (E), IL-23p19 
(F) and Activin A (G). Expression was normalized against the housekeeping gene HPRT.   
A representative of one of two individual experiments is shown with mean ± SEM. Statistical 
analysis was performed defining differences to IL-4R -/lox mice (*, p ≤ 0.05, **, p ≤  0.01). 
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 mice  
It is well known that macrophage killing by iNOS-catalyzed nitric oxide production is a 
key feature of an effective anti-leishmanial immune response. However, a recent 




 inflammatory DCs in 
controlling Leishmania infection (De Trez et al., 2009). We therefore examined iNOS 








BALB/c mice, a significantly reduced percentage of CD11b
+
 DCs produced iNOS 
compared to IL-4R
-/lox 
littermate controls (Figure 3.22A). In addition, intracellular levels 
of iNOS expression were also lower (Figure 3.22B). Together, these data demonstrate that 
IL-4R -deficient CD11b
+ 
DCs have impaired killing effector functions, which most likely 





BALB/c mice. Moreover, iNOS-producing DCs appear to influence control over L. major 



















Figure 3.22: Abrogation of IL-4R  expression in dendritic cells impairs iNOS expression.  
CD11ccreIL-4R -/lox and control mice were infected subcutaneously with 2×106 stationary phase 
metacyclic GFP-L. major IL81 promastigotes into the hind footpad. Total lymph node cells were 
surface-stained and gated for CD11b+CD11c+MHCII+ DCs followed by intracellular staining for 
iNOS. 
(A) Percentage of CD11b+ inflammatory DCs producing iNOS.  
(B) Intracellular iNOS expression shown as population shifts in CD11b+CD11c+MHCII+ 
inflammatory DCs from CD11ccreIL-4R -/lox and control mice.  
A representative of one of two individual experiments is shown with mean values ± SEM. 






































































Understanding the underlying mechanisms of pathogenesis and immune control in murine 
models of cutaneous Leishmaniasis will aid in the design of effective therapeutics and 
vaccines. During acute L. major infection in mice, Th1 cells provide protection through 
production of IL-12, IFN-  and TNF, which promotes classical activation of macrophages 
and killing of intracellular parasites by effector nitric oxide production (Sypek et al., 1993; 
Wei et al., 1995; Guler et al., 1996). In contrast, Th2 cells promote infection by secretion 
of IL-4, IL-13, IL-5 and IL-9 cytokines, which counter-regulate Th1 responses, impair 
classical activation of macrophages and induce arginase I production by alternatively 
activated macrophages that favour parasite growth and survival (Kopf et al., 1996; 
Matthews et al., 2000; Arendse et al., 2005; Holscher et al., 2006).  
Although several studies have clearly established that IL-4 is a key cytokine in the 
development of non-healing disease in BALB/c mice (Sadick et al., 1990; Launois et al., 
1995; Kopf et al., 1996; Himmelrich et al., 2000), apparently contradictory evidence also 
suggests that IL-4 has the ability to instruct protective Th1 responses (Noben-Trauth et al., 
1996; Noben-Trauth et al., 1999; Biedermann et al., 2001). Usually, L. major parasites 
down-modulate protective immunity and establish non-healing disease in susceptible 
strains by suppressing the induction of IL-12 production in macrophages and dendritic 
cells (Carrera et al., 1996; Belkaid et al., 1998; Moll et al., 2002; Liu et al., 2009). The 
term “instruction theory” was coined when exogenously administered IL-4, but not IL-13, 
was found to increase DC-derived IL-12 production induced by pathogen products, via 
signaling through the type I IL-4 receptor complex (Hochrein et al., 2000; Biedermann et 
al., 2001; Lutz et al., 2002). Several studies also indicate that both IL-4 and IL-13 play a 
role in promoting DC maturation via signaling through the type II IL-4 receptor complex 
(Lutz et al., 2002; Padilla et al., 2005). As it was unclear how IL-4 induces IL-12 
production in DCs, studies investigated IL-10 as a possible mediator of this process since 
this immunosuppressive cytokine was shown to inhibit IL-12 production by DCs 
(D'Andrea et al., 1993). Indeed, Yao and colleagues clearly demonstrated that the 
mechanism behind DC instruction was inhibition of IL-10 by IL-4, leading to higher levels 
of IL-12 and increased protective Th1 responses (Yao et al., 2005).  
Most in vitro and in vivo studies on the effects of IL-4 have been conducted with 











during disease in vivo had not been demonstrated. To address these issues, dendritic cell-






BALB/c mice were generated by gene-
targeting using the cre/loxP recombinase system under control of the CD11c locus. These 
mice were found to have abrogated IL-4R  expression on DCs and alveolar macrophages, 
with other cell types maintaining normal IL-4R  expression and function (Hurdayal and 





mice with L. major LV39 and IL81 parasites revealed IL-
4R  signaling on DCs to be highly important in protection against cutaneous 
Leishmaniasis. Compared to IL-4R
-/lox 





mice showed dramatically worsened disease progression, with greater 
footpad swelling and necrosis, and significantly higher parasite burdens both locally and in 
visceral organs such as the spleen and liver. As expected, genetically resistant C57BL/6 
mice effectively controlled infection, as did global IL-4R
-/-
 mice, which have been shown 
to be resistant during the acute phase of L. major infection, with disease progression in the 
chronic phase only (Mohrs et al., 1999; Radwanska et al., 2007).  
Progressive disease during L. major infection in BALB/c mice has been attributed to the 
predominance of CD4
+ 
Th2 cells, Th2 cytokines and type 2 antibody responses 
(Himmelrich et al., 2000; Matthews et al., 2000; Arendse et al., 2005; Holscher et al., 
2006; Radwanska et al., 2007). Analysis of CD4
+





 mice revealed a decrease in IFN-  accompanied by a marked increase in IL-4, IL-
13 and IL-10, while augmented secretion of IgG1 and IgE antibodies by B cells confirmed 
a shift towards a susceptible Th2-type immune phenotype. In agreement with the 
“instruction theory”, inhibition of IL-4 signaling on DCs reduced the protective Th1 
immune phenotype while enhancing a disease promoting Th2 phenotype. The reduced Th1 




mice demonstrate that IL-4-mediated 
DC instruction theory is relevant in vivo, with biological quantities of IL-4 acting through 




mice restimulated with Leishmania antigen secreted more IL-10 and less IL-12 than those 
from IL-4R
-/lox 





produced more IL-10 and less IL-12, thereby confirming impaired IL-4-mediated DC 
instruction in vivo in CD11ccreIL-4R -/lox mice and a role for IL-4R  signaling in 











Aside from its role in instruction, IL-10 is known to be a susceptibility factor during L. 
major infection, being produced at higher levels in susceptible BALB/c mice, and is 
capable of suppressing both Th1-mediated effector functions (Heinzel et al., 1991; Kane 
and Mosser, 2001; Noben-Trauth et al., 2003) and development of delayed type 
hypersensitivity (DTH) responses (Radwanska et al., 2007). In humans, IL-10 is strongly 
associated with persistent L. major infection (Anderson et al., 2005). Quantification of 
mRNA expression also revealed decreased expression of the genes for Th1-promoting 




mice compared to 
littermate control DCs, while expression of the genes for Th2-promoting cytokines, IL-
23p19 and Activin A, were significantly increased. IL-23 production by DCs has been 
shown to induce the expansion of Th17 cells which in turn increases the recruitment of 
neutrophils to the site of infection that promote susceptibility to L. major (Lopez Kostka et 
al., 2009).  
Neutrophils are typically recruited within hours to the site of parasite inoculation with 
qualitative and quantitative differences being observed between susceptible and resistant 
mouse strains (Tacchini-Cottier et al., 2000). In BALB/c mice, a sustained recruitment of 
elevated numbers of neutrophils persists, which does not occur in resistant C57BL/6 mice. 
Indeed, these professional phagocytes have been shown to enhance susceptibility to L. 
major through production of inhibitory cytokines, such as IL-10 and TGF- , and by acting 
as “Trojan horses” for Leishmania entry into their final host cells, the macrophages 
(Tacchini-Cottier et al., 2000; Laskay et al., 2003; van Zandbergen et al., 2004; Charmoy 
et al., 2007). Along with other studies (Ritter et al., 2009), we also found neutrophils at the 
site of infection harboring L. major parasites and infected cell numbers increased 
substantially during disease progression. These data illustrate a paradox of neutrophil 
function in cutaneous Leishmaniasis. Although these cells are actively involved in host 
innate defense to the parasite, they also contribute to pathology and enhance susceptible 
Th2 responses during infection (Tacchini-Cottier et al., 2000; Sacks and Noben-Trauth, 
2002). Activin A is a pleiotropic cytokine belonging to the TGF-  superfamily, and has 
previously been found to promote alternative activation of macrophages by inducing 
Arginase I and decreasing IFN-  induced expression of iNOS (Ogawa et al., 2006). Given 
that CD11b
+




mice had increased Activin A and IL-10, it is 
possible that Activin A and/or IL-10 could have promoted impaired classical activation of 
CD11b
+ 











IFN-  plays an important role in mediating protective immunity during L. major infection 
by classically activating macrophages to induce iNOS-mediated NO production for 
intracellular killing of parasites (Liew et al., 1990; Stenger et al., 1994; Diefenbach et al., 
1999; Holscher et al., 2006). iNOS-deficient C57BL/6 mice are highly susceptible to L. 
major infection (Stenger et al., 1994; Wei et al., 1995) and latent Leishmaniasis is 
reactivated in chronically infected healthy C57BL/6 mice by inhibition of endogenous 
NOS-2 (Stenger et al., 1996; Holscher et al., 2006; De Trez et al., 2009). Together, these 
studies indicate that iNOS expression is crucial for the sustained control of L. major 
infection. Induction of iNOS-mediated NO production is counter-regulated by IL-4 and IL-
13, which promote the development of alternatively activated macrophages and arginase I 
production depleting L-arginine as a substrate for iNOS. IL-10 has also been shown to 
suppress intracellular killing of pathogens in macrophages by suppressing IFN-  responses 
(Bogdan et al., 1991; Gazzinelli et al., 1992; Kane and Mosser, 2001) and inducing an 
alternatively activated macrophage phenotype in the absence of IL-4 and IL-13 (Dewals et 
al., 2010). Parasites such as Leishmania can utilize polyamines generated by arginase I 
activity for their own growth thus making alternatively activated macrophages a favorable 
environment for their survival (Brombacher, 2000; Roberts et al., 2004; Kropf et al., 2005; 
Colotti and Ilari, 2011). Accumulating reports have demonstrated a role for alternative 
macrophage activation and arginase I expression in influencing susceptibility to L. major 





mice which lack IL-4/IL-13 induced alternative activation of 
macrophages were found to have increased resistance to infection (Holscher et al., 2006), 
while neutralization of endogenous arginase I with N-hydroxy-nor-L-arginine completely 
ameliorated disease progression in BALB/c mice (Kropf et al., 2005). Macrophages from 




 mice were found to have reduced iNOS expression and 
increased arginase I expression compared to those from littermate control IL-4R
-/lox
 mice, 
demonstrating a shift towards alternative activation of macrophages most likely as a 
consequence of increased IL-4, IL-13 or IL-10. 
iNOS expression was also decreased in CD11b
+





possibly as a consequence of reduced IFN-  and/or increased IL-10 and activin A. 
Moreover, CD11b
+




mice had higher L. major parasite loads 
than those from littermate controls correlating with the reduced iNOS expression. Previous 











cell population and contribute to resistance during infection by L. major (De Trez et al., 
2009), L. monocytogenes (Serbina et al., 2003) and Brucella sp. (Copin et al., 2007). De 
Trez et al. (2009) demonstrated that inflammatory CD11b+ DCs were the main iNOS-
producing cells in both the footpad lesion and the draining lymph node of L. major infected 
C57BL/6 mice and that the induction of iNOS expression in these cells required a local 
Th1 microenvironment. On the other hand, a Th2 microenvironment inhibited the 
differentiation and activation of iNOS
+
 inflammatory DCs which highlighted an important 
role for IL-4 and IL-13 as negative regulators in the induction of these DCs. The reduced 




mice is therefore 
likely to play a role in the uncontrolled survival and replication of L. major parasites 
observed both in the footpad and at peripheral sites. 
In susceptible BALB/c mice, L. major parasites can disseminate within 24 hours from the 
site of infection in the footpad to the popliteal lymph nodes as well as to peripheral sites 
such as the spleen, liver, lungs and bone marrow (Laskay et al., 1995; Schilling and 
Glaichenhaus, 2001). Resistant mouse strains restrict the spread of the parasites and 





mice, L. major parasites were not detected in spleens at early 
time points during IL81 infection (day 1 and day 3) but by week 4, parasites were detected 
in the LN, spleen and liver. During LV39 infection, parasites were also detected at week 8 
in the LN, spleen and liver but at week 3, parasites were only detected in LN and not in 





mice may have occurred at a later stage of infection. While several susceptible 
mouse strains have been reported to show some increase in dissemination (Guy and 





 mice were dramatic, with relatively higher parasite burdens in the 
spleens and footpads compared to other strains. Unexpectedly, parasites were even 




 mice which has only rarely 
been reported for this cutaneous strain and with very low levels of parasites detected 
(Amini et al., 2008). However, dissemination of parasites to the central nervous system 
(CNS) has been frequently observed in visceral Leishmaniasis in both humans and canines 












It has been suggested that intracellular parasites can gain access to the CNS via infected 
leukocytes (Abreu-Silva et al., 2003) and/or disruption to the blood brain barrier caused by 
inflammation (Petersen and Greenlee, 2011). Studying the mechanisms by which other 
pathogens such as bacteria invade the CNS may lend insights into Leishmania major 
dissemination. Many intracellular organisms such as Mycobacterium tuberculosis, Listeria 
monocytogenes, Brucella spp. and Salmonella spp. appear to make use of the “Trojan-
horse” mechanism, using phagocyte-facilitated invasion for entry into the CNS (Drevets 
and Leenen, 2000; Drevets et al., 2004). In order to investigate which cells might act as a 
“Trojan-horse” and facilitate dissemination of L. major parasites to peripheral sites, 




 mice, animals were infected with GFP-
expressing L. major IL81 parasites and cell populations containing parasites were 
identified by flow cytometry.  
At day 3 and 7 after infection, macrophages were the predominant cell type harboring L. 
major in the footpad, while plasmacytoid DCs, or pDCs, and cDCs, specifically CD103+ 
tissue DCs, were the main infected cell type in the lymph nodes, indicating that these DCs 
could be initially responsible for transporting parasites to the lymph node. At week 4, L. 
major parasites were still detected in macrophages in the footpads as well as CD11b+ DCs 
and neutrophils, but primarily in CD11b
+
 inflammatory DCs in the lymph node. The 





 mice compared to littermate controls.  
A previous study also reported that DCs were the primary infected cell population in the 
draining LN of L. major infected mice (Muraille et al., 2003). Our study expands upon 
these findings by identifying that at the onset of infection it is CD103
+
 tissue DCs and 
pDCs that possibly transport parasites to the draining LN and later the inflammatory 
CD11b
+
 DCs that become parasitized. pDCs are in fact efficient at cell migration through 
expression of the chemokine receptor CXCR3, which enables their migration into inflamed 
lymph nodes in response to chemokines CXCL9 and CXCL10 (Yoneyama et al., 2004). 
Given the migratory capacity of pDCs and the fact that these cells are inefficient at 
antigen-presentation due to ineffective capturing, processing and MHC-loading of 
antigens, it seems likely that pDCs may instead serve as vectors that transport Leishmania 
antigen to the lymph nodes for final presentation by other DC subsets. Interestingly, 
eosinophils also appeared to phagocytose parasites and carry them to the lymph nodes. Not 











known to infiltrate the site of infection in the early phase and appear to be able to kill the 
parasites (Grimaldi et al., 1984; Belkaid et al., 2000; Watanabe et al., 2004). 
CD11b
+





 mice again showing a greater number of infected DCs, 
and higher parasite loads in the DCs. Numbers of CD11b
+





 mice and littermate controls, indicating that the increased survival 
and/or growth of parasites in these DCs due to inhibition of iNOS was responsible for the 
increase in infected cell numbers. Overall, the data suggest that CD11b
+
 dendritic cells 
may play a role in disseminating L. major parasites to peripheral organs such as the spleen, 
liver and brain and that their ability to kill parasites is impaired in the absence of IL-4R  
signaling.  
Interestingly, a recent study found that infected inflammatory DCs, which are monocyte-
derived CD11b
+
 DCs expressing Ly6C, F480, Ly6G and iNOS, showed a unique ability to 





 cells were found to be the principal phagocytic cells 
harboring L. monocytogenes in circulation (Drevets et al., 2004; Drevets and Bronze, 
2008). A study using DsRed-expressing L. major parasites to trace infected cells reported 
that CD11b
+ 







were also the major infected cell population in footpads and draining lymph nodes during 
infection in C57BL/6 mice (De Trez et al., 2009). This is in agreement with our data and 
together, these data suggest that inflammatory DCs may disseminate L. major and that 
their effector responses, such as iNOS expression, are important in controlling disease.  
Our results demonstrate that DC instruction by IL-4 during L. major infection in vivo 
promotes IL-12 production and has other effects on DC phenotype that collectively 
influence protective Th1 responses and disease outcome. Our findings on the role of IL-4-
mediated DC instruction in resistance to L. major can be summarized in the hypothetical 
model shown in Figure 4.1. In the absence of IL-4R -signalling on dendritic cells in L. 
major-infected CD11ccreIL-4R -/lox mice, IL-4 secreted into the microenvironment by 
V 4V 8 CD4
+
 T cells, basophils eosinophils and/or mast cells directly polarizes naïve T 











However, the Th2 response is exacerbated because DCs are no longer responsive to IL-4 
and therefore IL-12 production by DCs is decreased and IL-10 increased. This leads to 
poor parasite control and increased parasite persistence since IL-12 is the key cytokine that 




mice are therefore 
hypersusceptible to L. major. Hypersusceptibility is associated with a shift to Th2-type 
immune responses, with Th2 cytokines (IL-4, IL-13 and IL-10) providing a positive 
feedback loop for further activation and differentiation of CD4
+
 Th2 cells and induction of 
alternatively activated macrophages, which express increased arginase but reduced iNOS. 
Inhibition of iNOS favors Leishmania survival and growth leading to strikingly increased 























(A) In the absence of IL-4R  on dendritic cells (DCs) in CD11ccreIL-4R -/lox mice, IL-4 secreted 
by V 4V 8 CD4+ T cells, mast cells, eosinophils and/or basophils in the microenvironment prime 
naïve T cells towards Th2 cell differentiation. (B) DCs are no longer responsive to IL-4 (and IL-13) 
and IL-12 production by DCs is reduced with increased IL-10. Since IL-12 drives protective Th1 
responses, CD11ccreIL-4R -/lox mice are hypersusceptible to L. major infection and protective Th1 
responses are reduced. (C) Increased Th2 cytokines (IL-4, IL-13 and IL-10) continue to activate 
naïve cells towards Th2 differentiation and drive induction of alternatively activated macrophages 
(Mph) which secrete more arginase (Arg) and less iNOS, which favors Leishmania growth and 
survival, leading to higher parasite burdens in CD11ccreIL-4R -/lox mice. (D) IL-4R -deficient DCs 
also show reduced iNOS expression, which contributes to disease progression due to increased 

















mice also show reduced iNOS expression 
which also enhances disease progression due to increased survival of Leishmania parasites 
in infected DCs (Figure 4.1). The Th1-inducing effect of IL-4 may not be unique to 
cutaneous Leishmaniasis since early reports on visceral Leishmaniasis caused by L. 
donovani clearly demonstrated that expansion of Th2-type cells and their cytokines did not 
necessarily contribute to susceptibility in mice (Kaye et al., 1991). Moreover, IL-4-
deficient mice were unresponsive to sodium stibogluconate treatment and developed 
progressive disease indicating that effective treatment of visceral Leishmaniasis was 
dependent on endogenous levels of IL-4 (Alexander et al., 2000). High levels of IL-4 
elicited after vaccination with a liposomal formulation of Leishmania have also been 
shown to instruct a Th1 response and promote resistance to L. donovani infection in 
susceptible BALB/c mice (Mazumdar et al., 2004).  
Instruction theory may not be restricted to Leishmaniasis, since ther disease models have 
also demonstrated a protective role for IL-4 in promoting Th1 immune responses. 
Experimental infections with Candida albicans in IL-4 deficient mice led to impaired 
development of Th1 responses (Mencacci et al., 1998) and a Th1 promoting effect of IL-4 
has also been observed in autoimmunity (Erb et al., 1997; Bagley et al., 2000; Radu et al., 
2000), tumor immunity  (Tepper et al., 1989; Golumbek et al., 1991; Schuler et al., 1999) 
and contact sensitivity reactions (Salerno et al., 1995; Traidl et al., 1999). There is also 
evidence to suggest that IL-4 may promote Th1 development in humans, since both human 
and mouse DCs produce increased levels of bioactive IL-12 after stimulation with IL-4 
(Hochrein et al., 2000). A similar effect was observed in human peripheral blood 
mononuclear cells treated with IL-4 plus lipopolysaccharide or Staphylococcus aureus 
(D'Andrea et al., 1995). Furthermore, stimulation of human monocytes with IL-4 during 
interaction with T cells resulted in upregulated IL-12 production (Bullens et al., 2001).  
Incorporating exogenous IL-4 as an adjuvant for enhancing strong Th1 responses could 
therefore be utilised to boost vaccine efficiency against cutaneous Leishmaniasis. 
Accordingly, in parallel studies, we have examined the efficacy of IL-4 as an adjuvant 
during BMDC-mediated vaccination against L. major. In this study, vaccination of 
BALB/c mice with IL-4R -deficient BMDCs failed to immunize animals against acute L. 
major infection, possibly due to reduced IL-12 and increased IL-10 secretion by the 
vaccinating DCs. Conversely, IL-4-responsive BMDCs (DCs with a functional IL-4R ) 











immunized BALB/c mice against infection (Masic et al., 2012). These data demonstrate 
that IL-4-mediated instruction of DCs is critical in eliciting protective Th1 responses 
during vaccination of BALB/c mice against cutaneous Leishmaniasis. The role of IL-4R  
signaling on DCs in eliciting immunity to other intracellular pathogens is therefore of 
interest to vaccination strategies, and an exciting avenue to be explored. 
In conclusion, several studies had demonstrated a Th1-promoting effect of IL-4 in vitro or 
in vivo with exogenously administered IL-4, but the significance of IL-4-mediated DC 
instruction during disease in vivo had not been demonstrated. A dendritic cell-specific IL-




BALB/c mice) allowed us to investigate 
the in vivo effects of IL-4 and IL-13 through IL-4R  signaling on DCs during cutaneous 
Leishmaniasis. The results presented in this thesis clearly demonstrate that IL-4R  
mediated instruction of DCs occurs in vivo and impairment of IL-4R signaling on DCs is 
severely detrimental to the host. This leads to rapid progression of disease and increased 
dissemination of parasites to peripheral sites. It is also clear that IL-4R  signaling has 
additional, important effects on DC phenotype, which extends far beyond simply 
promoting IL-12 production during L. major infection. This study therefore expands our 
knowledge both on the role of dendritic cells and on the protective effects of IL-4R  
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PICTURE REFERENCES – FIGURE 1.6 
 
Cutaneous: http://www.who.int/leishmaniasis/cutaneous_leishmaniasis/en/index.html, 
Mucocutaneous: http://tmcr.usuhs.mil/tmcr/chapter46/leishman3.htm,  
Visceral: http://drugline.org/medic/term/visceral-leishmaniasis/,  



















1.   Anaesthetic 
1.2 ml Anaket-V (100 mg/ml) (Centaur labs, Isando) 
0.8 ml Rompun (2 %) (Bayer, Germany) 
Dissolve in 8.0 ml PBS (1×) and filter-sterilize 
2.   Phosphate Buffered Saline (PBS 10×) 
80g NaCl (1.37 M) 
2g KCl (0.03 M) 
14.4g H2PO4 (0.01 M) 
2.4g KH2PO4 
Dissolve in 1 L ddH2O 
In vitro Reagents: 
1.   Roswell Park Memorial Institute (RPMI) 
1 vial RPMI (Sigma-Aldrich) 
2 g NaHCO3 (37 g / L) 
800 ml ddH2O 
100 units/ml penicillin plus 100 g/ml streptomycin 
Adjust the pH to 7.2 – 7.4 
Make up to 1 L with ddH2O and filter sterilize 
2.   Complete RPMI 
10% heat-inactivated fetal calf serum (FCS) 
500 l 2- -mercaptoethanol (0.1 mM) 
5 ml L-Glutamine (200 mM) 
ELISA Reagents: 
1.   ELISA Blocking Buffer 
20g Milk powder (spar instant) (2 %) 
Make up to 1 L with 1× PBS 
2.   ELISA Carbonate Coating Buffer (Cytokine ELISA) 
100 ml 10× PBS 
1.6g Na2CO3 
2.9g NaHCO3 











Make to 1 L in ddH2O and pH 9.5 
3.   ELISA Coating Buffer (Antibody ELISA) 
100 ml 10× PBS 
8g BSA (Merck) 
Make to 1 L in ddH2O and pH 9.5 
4.   ELISA Dilution Buffer 
10g BSA (1 %) (Roche) 
0.2g NaN3 (0.02 %) (Merck) 
Make up to 1 L with 1× PBS 
5.   ELISA Substrate Buffer (for Alkaline Phosphatase conjugates) 
0.2g NaN3 (0.02 %) 
97 ml di-ethanolamine 
0.8g MgCl2.6H2O 
700 ml ddH2O 
Adjust the pH to 9.8 and make up to 1 L with ddH2O 
6.   ELISA Substrate Buffer (for Horseradish Peroxidase conjugates) 
Mix an equal volume of TMB Peroxidase Substrate Solution A and Peroxidase 
Substrate Solution B (Roche Diagnostics, Mannheim, Germany). Add 50 μl per well. 
50 l 1 M H3PO4 to stop the reaction 
7.   ELISA Washing Buffer 
20g KCL 20g KH2PO4 
144g NA2HPO4.H2O  
800g NaCl (Merck-BDH) 
50 ml Tween 20 (Sigma)  
100 ml 10 % NaN3 (Merck) 
Make up to 5 L with ddH2O 
In vivo Reagents: 
1.   Schneider’s Drosphilia Medium (Sigma-Aldrich) 
1 bottle Schneider’s Drosphilia Medium  
0.4 g sodium bicarbonate 
800 ml ddH2O 
Mix until dissolved. 











Stir for 10 minutes. Adjust the pH to 6.7 
Dissolve 0.6 g anhydrous calcium chloride in 50 ml water. Add to medium slowly. 
Equilibrated to a pH of 7.0  
Add 100U/ml penicillin G plus 100μg /ml streptomycin 
Make up to 1 L with ddH2O and filter-sterilize.  
Add 20 % heat-inactivated FCS before use. 
2.   Hank’s Balanced Salt solution (HBSS) 
1 vial HBSS (Invitrogen) 
Dissolved in PBS (1×) 
3.   Red Cell Lysis Buffer 
0.037g EDTA 
8.34g NH4CL  
1.0g NaHCO3    
Make to 1 L with ddH2O 
4.   Complete Dulbecco's Modified Eagle's Medium (DMEM) 
1 bottle DMEM (Gibco) 
10 % FCS 
1 % HEPES  
500 l 2- -mercaptoethanol (0.1 mM)  
100U/ml penicillin G plus 100μg /ml streptomycin  
5.   FACS Buffer 
1 g BSA (0.1%) 
100 ml 1× PBS 
Make up in 1 L in ddH2O 
6.   MACS Buffer 
50 ml 1× PBS 
5 g BSA (0.5 %) 
0.372 g EDTA (2 mM) 
Make up to 500 ml in ddH2O 
7. Permebilization Buffer 
0.5 g Saponin 
0.055 g CaCl2 











0.25 g NaN3 (0.5g/L) 
0.5 g BSA (1g/L) 
10 mM Hepes (5 ml of 1 M Hepes) 
50 ml 1× PBS 
Adjust to pH 7.4.  
Make up to 500 ml in ddH2O. Filter-sterilize. 
NO and Arginase assays: 
1.   Griess Reagent Standard (1mM NaNO2) 
6.899 mg NaNO2 
Dissolve in 100 ml of ddH2O and store at 4
o
C. 
2.   Griess Reagent 1 
1 g sulfanilamide 
Dissolve in 100 ml 2.5% phosphoric acid. Cover bottle in foil and store at 4
o
C. 
3.   Griess Reagent 2 
0.1 g napthyl-ethylene-diamine 
Dissolve 100 ml 2.5 %phosphoric acid. Cover bottle in foil and store at 4
o
C. 
4.   2.5 % phosphoric acid 
3 ml 85 % phosphoric acid 
Dissolve in 90 ml of ddH2O. Bring up volume to 100 ml. 
 
